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Message of the 
Congress President
Dear Colleagues,
On behalf of the Organising Committee, I have the pleasure of welcoming you
to the 10th World Congress of the International Society for Adaptive Medicine
(ISAM), which will be held in Bucharest, between 7 and 10 of June, 2012.
This meeting is gathering World experts, from more than 35 countries, who
will present the cutting edge advances in medical science, covering the
meaning of the transitive verb ‘to adapt’: „Alter or modify to fit for a new use,
new conditions”.
Promoting a cultural attitude by putting the change or adaptation in the
middle of our debate, we expect that a new thinking will emerge. We anticipate
that trans-disciplinar and translational approaches which are to be presented
these days are going to contribute to the improvement of medical knowledge
in the years to come.
The perspectives that invited speakers (about 120) will offer are as varied as
their fields of interest. From imaginative reinvention of medical approaches to
the concept of trendsetter in science, I believe the Congress agenda truly
includes something for everyone. It was our intention to provide an inspiring
atmosphere for fruitful scientific discussion and for initiating new
collaborations in this „adaptive medicine” community.
I hope you will enjoy our scientific and social programmes during your stay
in Bucharest.
Yours truly,
Professor L.M. Popescu, MD, PhD, h.c. mult.
President of the Organizing Commitee
Bucharest, June 2012
Welcome Message 
Dear Delegates: 
As Honorary Life President and a Founding Member of the International
Society for Adaptive Medicine, it gives me a great pleasure to extend a warm
welcome to all the delegates to the 10th World Congress of the ISAM, being
held in the Hotel Intercontinental, Bucharest, Romania, under the
Chairmanship of Prof. Lawrence Popescu.  The 10th World Congress appears
to be one of the strongest in its scientific content.  The conference indeed
provides a very good forum to bring together scientists from different parts of
the world and from different disciplines around the focus of adaptation for a
cross-fertilization of ideas.
I am most pleased to share with you that our volunteer organization is in great
shape.  We would be publishing the proceedings from this conference as Volume
7 of the series “Adaptation Biology and Medicine”.  We already have a venue
for the 11th World Congress, which will be held in 2014 in Japan.  
I am myself looking forward to a wonderful time in Bucharest, Romania.  On
behalf of the Society, I do express my gratitude to the Organizers for their
dedicated efforts.  May you enjoy the conference as well as your stay, and may
you also build further lifetime friendships.
Yours Sincerely,
Dr. Pawan K. Singal, PhD, DSc
Honorary Life President
International Society for Adaptive Medicine
Winnipeg, Canada
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Plenary lectures
(in alphabetical order)
P-1   P. Anversa
Harvard University, Boston, USA
Mechanism of Cardiac Repair
Thursday, June 7th, 17:30, Main Hall (Ronda)
P-2   S.N. Constantinescu
Ludwig Institute for Cancer Research, Brussels, Belgium
Actors of Blood Regeneration: Erythropoietin, Thrombopoietin and
their Receptors
Friday, June 8th, 16:00, Main Hall (Ronda)
P-3   Maria-Simonetta Faussone-Pellegrini
Florence University, Florence, Italy
The Interstitial-Stromal Cells: State of the Art
Friday, June 8th, 11:00, Main Hall (Ronda)
P-4   R.E. Horch
Friedrich-Alexander Universitat, Erlangen, Germany
Tissue Engineering – Where Do We Stand?
Saturday, June 9th, 16:00, Main Hall (Ronda)
P-5   M. Ivan
Indiana University, Indianapolis, USA
The Ever Expanding Universe of Hypoxia
Saturday, June 9th, 11:00, Main Hall (Ronda)
P-6   S. Kostin
Max-Planck-Institute, Bad Nauheim, Germany
Dhalla Lecture: Cardiomyocytes in Cardiac Repair
Sunday, June 10th, 11:00, Main Hall (Ronda)
P-7   B. Winblad
Karolinksa Institutet, Stockholm, Sweden
Re-Thinking Alzheimer Disease Therapy; Lessons Learned From
Ongoing Clinical Trials
Thursday, June 7th, 18:30, Main Hall (Ronda)
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P-1
MECHANISM OF CARDIAC REPAIR
Piero Anversa
Harvard University, Boston, USA
panversa@partners.org 
The identification of cardiac progenitor cells in small and large mammals
raises the possibility that the human heart contains a population of stem cells
capable of generating cardiomyocytes and coronary vessels. We established
the conditions for the isolation and expansion of c-kit-positive hCSCs from
small fragments of myocardium discarded at surgery. Additionally, we tested
whether these cells have the ability to form functionally competent human
myocardium after infarction in immunodeficient and immunosuppressed
animals independently of cell fusion. We have documented that c-kit-positive
human cardiac cells possess the fundamental properties of stem cells: they are
self-renewing, clonogenic and multipotent. hCSCs differentiate predominantly
into cardiomyocytes and to a lesser extent into smooth muscle cells and
endothelial cells. When locally injected in the infarcted myocardium of
immunodeficient mice and immunosuppressed rats, hCSCs generate a
chimeric heart, which contains human myocardium composed of myocytes,
coronary resistance arterioles and capillary profiles. Importantly, the
differentiated human cardiac cells possess only one set of human sex
chromosomes excluding cell fusion. Although the human myocardium shows
an immature phenotype, it contracts regionally and contributes to the
improvement in the hemodynamic performance of the infarcted left ventricle.
These experimental findings constituted the basis for pre-clinical studies in
large animal models and for the recent phase 1 trial SCIPIO (Stem Cell
Infusion in Patients with Ischemic cardiOmyopathy). One million autologous
hCSCs were administered by intracoronary infusion ~4 months after multi-
by-pass surgery in patients with chronic ischemic cardiomyopathy. No hCSC-
related adverse effects were reported. The initial results of the SCIPIO trial
are very encouraging; intracoronary infusion of autologous CSCs improved
left ventricular systolic function and reduced infarct size in patients with severe
heart failure after myocardial infarction. 
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P-2
ACTORS OF BLOOD REgENERATION:
ERyTHROPOIETIN, THROMBOPOIETIN AND
THEIR RECEPTORS
Stefan N. Constantinescu
Signal Transduction & Molecular Hematology Unit,
Ludwig Institute for Cancer Research Ltd.,
de Duve Institute, Université catholique de Louvain,
Brussels, Belgium
stefan.constantinescu@bru.licr.org
Erythropoietin (Epo), thrombopoietin (Tpo) and Granulocyte-Colony
Stimulating Factor (G-CSF) regulate production of red blood cells, platelets
and granulocytes. These cytokines bind to specific receptors displayed at the
surface of erythroid, megakaryocytic and granulocytic progenitors,
respectively, and induce anti-apoptotic, proliferative and differentiation
signals, by activation of JAK2 tyrosine phosphoryation and activation of
STAT5/3, MAP-kinase and phosphatydylinositol-3’-kinase pathways. Epo,
Tpo and G-CSF maintain steady state myeloid hematopoiesis, and also
mediate emergency myeloid production. An increased level of phosphorylation
of cytosolic receptor tyrosines mediates the latter effects.  Tpo also regulates
hematopoietic stem cell (HSC) quiescence, and G-CSF induces liberation of
HSCs from the marrow to periphery. The number of myeloid progenitors
appears to regulate the percentage of HSCs that are quiescent, and those that
enter blood formation. Genetic deletions of distal intracellular receptor regions
induce hypersensitivity to cytokines. Such deletions in G-CSFR predispose to
acute myeloid leukemia. Activating mutations in TpoR are associated with
myeloproliferative neoplasm. In contrast, EpoR is not involved in hematologic
malignancies, but Epo treatment might to favor evolution of certain solid
cancers, possibly by effects on angiogenesis, or directly on tumors. We will
discuss the emerging epigenetic cues that regulate signaling by Epo, Tpo and
G-CSF, and whether HSCs are the source of chronic and committed
progenitors of acute blood cancers.
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P-3
INTERSTITIAL-STROMAL CELLS: 
STATE OF THE ART
Maria-Simonetta Faussone-Pellegrini 
Department of Anatomy, Histology and Forensic Medicine,
University of Florence, Florence, Italy
s_faussone@unifi.it 
The resident connective tissue cells are usually named “interstitial” or ‘stromal
cells’. According to authors and depending on where they reside, these cells
have received a variety of names. However, so many cell types cannot exist
and some of them are likely a unique cell type known with different names.
Their morphological characteristics are reviewed with the aim to find criteria
for a sure identification and an appropriate name. We conclude stromal and
interstitial cells are too vague terms. Fibroblasts are the cells engaged in
ground substance and fiber synthesis. Myofibroblasts and myoid cells are not
true stromal cells. Interstitial cells of Cajal are located in the gut muscle coat
only, have specific morphology and contacts with smooth muscle cells and
nerve endings and play spontaneous electrical activity. Interstitial Cajal-like,
fibroblast-like and PDGRFα-positive cells are names to be avoided since
indicating a similarity with a cell type or a chemical property but not true cell
nature or morphology. Telocytes appear as a new interstitial cell type having
specific morphology and roles. Possibly, there are many telocyte subtypes and
their identification with some of the afore-mentioned cell types, or with
pericytes, periendothelial, adventitial, reticular, covering/perigangliar,
perineural cells or, in particular, with fibrocytes deserves discussion.
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P-4
TISSUE ENgINEERINg 
AND REgENERATIVE MEDICINE – 
WHERE DO WE STAND?
Raymund E. Horch
Kneser U., Beier J.P., Polykandriotis E., Schmidt V.J., 
Boos A.M., Bleiziffer O., Sun J., Arkudas A.
Department of Plastic and Hand Surgery And Laboratory
for Tissue Engineering and Regenerative Medicine,
Friedrich Alexander University, Erlangen-Nuernberg,
Germany
Raymund.Horch@uk-erlangen.de 
Tissue Engineering (TE) in the context of Regenerative Medicine (RM) has
been hailed for many years as one of the most important topics in medicine in
the 21st century. While the first clinically relevant TE efforts were mainly
concerned with the generation of bioengineered skin substitutes, subsequently
TE applications have been continuously extended to a wide variety of tissues
and organs. The advent of either embryonic or mesenchymal adult stem cell
technology has fostered many of the efforts to combine this promising tool
with TE approaches and has merged the field into the term Regenerative
Medicine. As a typical example in translational medicine the discovery of a
new type of cells called Telocytes that have been described in many organs
and have been detected by electron microscopy opens another gate to RM.
Besides cell therapy strategies the application of gene therapy combined with
tissue engineering have been investigated to generate tissues and organs. The
vascularisation of constructs plays a crucial role besides the matrix and cell
substitutes. Therefore novel in vivo models of vascularisation have evolved
allowing axial vascularisation with subsequent transplantation of constructs.
This article is intended to give an overview over some of the most recent
developments and possible applications in RM through the perspective of TE
achievements and cellular research. The synthesis of tissue engineering with
innovative methods of molecular biology and stem cell technology appears to
be very promising. 
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P-5
THE EVER ExPANDINg 
UNIVERSE OF HyPOxIA
Mircea Ivan
Departments of Medicine, Microbiology and Immunology
Indiana University Melvin and Bren Simon Cancer Center
Walther Hall, Indianapolis, USA
mivan@iupui.edu
Hypoxia is a feature of the tumor microenvironment and a key contributor to
the failure of conventional cancer treatment; therefore a detailed understanding
of this complex process has significant translational implications. The response
to oxygen deprivation involves diverse transduction pathways, arguably the
best understood being centered on the Hypoxia Inducible Factor (HIF). HIF
is directly regulated by the cellular oxygen sensors (HIF-prolyl and asparaginyl
hydroxylases) and coordinate the transcription of hundreds of protein-coding
genes. Starting with our earlier studies, HIF was also shown to induce non-
coding RNA species, and in particular microRNAs. Of these, miR-210 has
emerged as a versatile player in cancer biology, impacting cell metabolism,
proliferation, DNA repair and angiogenesis. 
In parallel, we are investigating additional cellular oxygen sensing pathways.
We have recently identified a HIF-independent, dihydroceramide (DHC) -
based response to hypoxia. Enzymatic processing of DHCs by the DEGS1 and
2 desaturases meets the criteria of an oxygen sensor, regulating the balance
between biologically-active components of ceramide metabolism in vitro and
in vivo.
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P-6
CARDIOMyOCyTES IN CARDIAC REPAIR
Sawa Kostin
Max-Planck-Institute for Heart and Lung Research,
Bad Nauheim, Germany
Sawa.Kostin@mpi-bn.mpg.de 
Cardiac myocytes in mammalian hearts are thought to be terminally
differentiated cells unable to fully re-enter the cell cycle. We show that lower
vertebrate cardiomyocytes do go through a process of cell dedifferentiaton,
proliferation and redifferentiaton to repair myocardial injury. Recently we have
demonstrated the underlying mechanism regulating dedifferentiation of adult
mammalian cardiomyocytes using varoius in vitro and in vivo models,
including myocardial infarction and dilated cardiomyopathy. Specifically,
inflammatory cytokines of the interleukin 6 family is induced at high levels
in human patients and initiates dedifferentiation of cardiomyocytes. Most
importantly, we demonstrate that cardiomyocyte dedifferentiation and loss of
sarcomeric structures in diverse cardiac diseases is associated with the re-
expression of different fetal markers, such as ANP and smooth muscle actin,
and increased expression of stem cell markers Runx1, c-kit and Dab-2. These
novel findings imposes a reconsideration of the mechanisms involved in
cardiomyocyte dedifferentiaton in adult mammalian hearts that may lead to
methods to promote cardiomyocyte regeneration in the human heart.
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P-7
RE-THINKINg ALzHEIMER’S DISEASE THERAPy;
LESSONS LEARNED 
FROM ONgOINg CLINICAL TRIALS
Bengt Winblad
Karolinska Institutet Alzheimer Disease Research Center,
Stockholm, Sweden
b-winblad-kaspac@nvs.ki.se 
Research into Alzheimer’s disease (AD) has been at least partly successful in
terms of developing symptomatic treatments, but has also had several failures
in terms of developing disease-modifying therapies. These successes and failures
have led to debate about the potential deficiencies in our understanding of the
pathogenesis of AD and potential pitfalls in diagnosis, choice of therapeutic
targets, development of drug candidates, and design of clinical trials. 
Many clinical and experimental studies are ongoing, mainly based on anti-
amyloid-β (Aβ) strategies, but the exact role played by Aβ in AD pathogenesis
is not yet clear. We need to acknowledge that a single cure for AD is unlikely
to be found and that the approach to drug development for this disorder needs
to be reconsidered. 
Preclinical research is constantly providing us with new information on pieces
of the complex AD puzzle, and an analysis of this information might reveal
patterns of pharmacological interactions instead of single potential drug
targets. The first signs of a shift away from linear “one protein - one drug
thinking” have already appeared: research is moving from proteins to focus
on organelles (eg mitochondria) and also multi-target-directed ligands.
Despite the recent negative results of RCTs on AD, increased collaboration
between pharmaceutical companies, basic and clinical researchers will bring us
closer to developing an optimum pharmaceutical approach for the treatment of
AD. A better understanding of the disease pathogenesis, but also solving
methodological problems in clinical trials on AD - eg standardized diagnostic
criteria to identify homogenous group of patients, appropriate treatment duration
and measures of disease-modifying effects - will help finding a cure for AD.
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S-01 Symposium 
“Adaptation to hypoxia: friend or foe”
Chaired by: M. Ivan, Susanne Schlisio
Date: Friday, June 8th
Starting time: 08:30 
Location: Main Hall (Ronda)
1. C. Koumenis 
Unfolded Protein Response
2. g. Melillo
Pharmacological Applications of HIF Pathway
3. Susanne Schlisio
Prolyl Hydroxylases
4. M. Ivan
Non-coding RNA in Hypoxia
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S01-1
THE ROLE OF THE INTEgRATED STRESS RESPONSE IN
HyPOxIA ADAPTATION AND TUMOR gROWTH
Stacey Lehman1,2, Carly M. Sayers1,3, Lori Hart1, Constantinos Koumenis1
1Department of Radiation Oncology, 2CAMB Graduate Program,
3Pharmacology Graduate Program, University of Pennsylvania Perelman
School of Medicine, Philadelphia, PA, USA
Costas.Koumenis@uphs.upenn.edu
Hypoxia and nutrient deprivation are dynamic features of the tumor
microenvironment that contribute to cancer progression and treatment
resistance. We previously showed that hypoxia activates the endoplasmic
reticulum (ER) kinase PERK thereby inducing phosphorylation of the
translation initiation factor eIF2α on ser51. We also demonstrated that the
nutrient-sensing kinase GCN2, similarly activates eIF2α phosphorylation in
response to amino acid and glucose deprivation. Phosphorylation of eIF2α
reduces energy expensive processes, but also promotes more efficient
translation of stress-responsive genes, such as ATF4, a transcription factor
which promotes adaptation to ER stress. The phosphorylation of eIF2α and
the upregulation of ATF4 represent a common mechanism activated by
different stresses, thereby termed the Integrated Stress Response (ISR).
Disruption of the ISR in cells dramatically affects their proliferation and
survival under hypoxia and nutrient stress and their ability to grow tumors.
Here, we will present new data supporting a role of the ISR, and particularly
GCN2 and ATF4, in promoting tumor angiogenesis and metastasis. Together,
our data suggest that transformed cells activate the ISR as an adaptation to
oxygen and nutrient deprivation and that disruption of this pathway
compromises tumor growth. Targeting the ISR by pharmacological inhibitors
is a promising emerging anti-tumor modality.
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S01-2
TARgETINg THE HyPOxIC TUMOR MICROENVIRONMENT
FOR CANCER THERAPy 
Giovanni Melillo
Discovery Medicine – Oncology
Bristol-Myers Squibb, Princeton, NJ, USA
Giovanni.Melillo@bms.com 
Low oxygen levels (hypoxia and/or anoxia) are frequently detected in human
cancers and are a hallmark of the tumor microenvironment.  Hypoxia
profoundly affects the behavior of cancer cells by inducing a shift in tumor
metabolism, increasing the production of angiogenic factors and activating
pathways that mediate invasion and metastasis. Overall, a hypoxia tumor
microenvironment has a negative influence on the potential efficacy of
chemotherapy and radiation therapy, and is ultimately associated with poor
patients’ prognosis. Conversely, intra-tumor hypoxia may represent a unique
opportunity for the development of therapeutic approaches that selectively
target hypoxic cells, sparing normal oxygenated tissues. Hypoxia Inducible
Factor 1 (HIF-1) is a master regulator of the transcriptional response to low
oxygen levels. Several approaches have been pursued to develop small
molecules targeting HIF-1. Although the majority of HIF-1 inhibitors
identified lack specificity, evidence of target modulation associated with anti-
tumor activity has been provided both in xenograft models and in early clinical
trials. Combination therapies with antiangiogenic agents, thought to increase
intra-tumor hypoxia, may provide a unique setting in which to exploit HIF-
targeted therapies. Given the challenges associated with directly targeting HIF-
1, many strategies have been proposed to target downstream mediators of HIF
transcriptional activity. Evidence will be discussed that highlights novel
pathways triggered by intra-tumor hypoxia, which may represent viable targets
for the development of novel cancer therapeutics.
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S01-3
OxygEN SENSINg AND CANCER
Susanne Schlissio
Ludwig Institute for Cancer Research Ltd
Karolinska Institutet, Stockholm, Sweden
Susanne.Schlisio@licr.ki.se 
O2-sensing is mediated partly via a family of enzymes called EglN prolyl
hydroxylases, a family that requires molecular oxygen for enzymatic activity.
Our work specifically focuses on how EglN3 execute apoptosis in neural
precursors during development and how disruption of this process can lead to
certain forms of nervous system tumors. Accordingly, our research is focused on: 
(1) The molecular mechanism of how the prolyl hydroxylase EglN3 executes
apoptosis in neural precursors during development; and 
(2) How failure of developmental apoptosis mediated by EglN3 predisposes
to certain forms of nervous system tumors.
Using a genome-wide RNAi-screen, we identified a novel tumor suppressor
called KIF1Bβ, a kinesin motor protein. KIF1Bβ is located on chromosome
1p36.2, a region of the genome that is frequently deleted in neural crest derived
tumors including neuroblastoma. We recently demonstrated that KIF1Bβ acts
downstream of EglN3 and is both necessary and sufficient for neuronal
apoptosis when NGF becomes limiting. The underlying mechanism behind
EglN3 regulation of KIF1Bβ remains unknown. We have now continued to
investigate how this kinesin induces apoptosis.
Further we completed additional EglN3-RNAi screens and identified genes
that are involved in apoptosis, transcriptional regulation, and the endosomal
system. Interestingly, several of the genes identified in this screen reside on
chromosomal loci that are frequently altered in neuroblastoma.
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S01-4
NON-CODINg RNA IN HyPOxIA
Mircea Ivan 
Departments of Medicine, Microbiology and Immunology
Indiana University Melvin and Bren Simon Cancer Center
Walther Hall, Indianapolis, USA
mivan@iupui.edu
Hypoxia is a hallmark of cancer microenvironment and a significant
contributor to the failure of conventional antineoplastic therapy. We have
previously shown that the hypoxia-activated transcriptome includes noncoding
RNAs that play important roles in cancer and ischemic disorders.
Arguably the best understood to date is miR-210, which regulates a variety of
cellular processes, including apoptosis, proliferation and energy metabolism.
Clinically, miR-210 is upregulated in most solid cancers and generally
correlated with adverse prognosis. The presentation highlights our latest
understanding of miR-210’s biological roles, based on newly developed
molecular strategies and animal models.
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S-02 Symposium 
“Inflammation and Sepsis”
Chaired by: F.Lupu, R.P. McEver
Date: Friday, June 8th
Starting time: 08:30 
Location: Hall A (Rapsodia)
1. T.E. Mollnes
Targeting complement activation and CD14-mediated
TLR signaling as potential therapy in sepsis
2. R.P. McEver
Leukocyte adhesion and signaling on vascular surfaces
during inflammation
3. g.T. Kinasewitz
Coagulopathy of sepsis: view from the bedside
4. F. Lupu
Pathophysiology, staging and therapy of severe sepsis
5. Cristina Lupu
Regulation of tissue factor dependent coagulation
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S02-1
TARgETINg COMPLEMENT ACTIVATION 
AND CD14-MEDIATED TLR SIgNALINg 
AS POTENTIAL THERAPy IN SEPSIS
Tom E. Mollnes
Somatic Research Center, Nordland Hospital, Bodø and University of
Tromsø, Norway
Department of Immunology, Oslo University Hospital and University of
Oslo, Norway
t.e.mollnes@medisin.uio.no 
Complement and Toll-like receptors (TLR) are main pattern recognition- and
effector systems in innate immunity. Thus, they act up-stream in defense
against intruding pathogens and endogenous damage signals. An extensive
cross-talk between these systems renders them particularly attractive as targets
for combined therapeutic intervention. CD14 is a key molecule in the TLR
family since it acts as co-receptor for several of the TLRs, including TLR4
and TLR2. C3 and C5 are essential complement components common for all
activation pathways. We have shown that combined inhibition of CD14 and
complement (C3 or C5) efficiently and synergistically attenuates the
inflammatory reaction induced by both Gram-negative and Gram-positive
bacteria. Cytokine production, adhesion molecule upregulation, oxidative burst
and procoagulant effects were virtually abolished in vitro in human whole
blood incubated with bacteria and in vivo in a pig sepsis model by the
combined treatment regimen, in contrast to single inhibition of CD14 or
complement. We postulate this combined approach as a general treatment
regimen to attenuate inflammatory responses induced by innate immunity. 
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S02-2
LEUKOCyTE ADHESION AND SIgNALINg ON VASCULAR
SURFACES DURINg INFLAMMATION
Rodger P. McEver
Oklahoma Medical Research Foundation, Oklahoma City, USA
odger-mcever@omrf.org 
Circulating leukocytes emigrate into lymphoid organs or inflamed sites
through sequential adhesive and signaling events. They tether to and roll on
endothelial cells, then decelerate, arrest, and crawl into underlying tissues.
Selectin-ligand interactions mediate tethering and rolling, whereas integrin-
ligand interactions mediate deceleration, arrest, and crawling. L-selectin,
expressed on leukocytes, binds to ligands on other leukocytes and some
endothelial cells. P-selectin, expressed on activated platelets and endothelial
cells, and E-selectin, expressed on activated endothelial cells, bind to ligands
on leukocytes. Cell adhesion faces major kinetic and mechanical constraints
in flowing blood. Bonds between adhesion molecules must form rapidly, and
their lifetimes are affected by the forces applied by shear stress. Clustering of
adhesion receptors in membrane domains modulates their functions. Engaging
selectin ligands on rolling neutrophils triggers a lipid raft-dependent signaling
cascade that serially activates Src family kinases, Syk, Bruton’s tyrosine
kinase, and p38. These and other signals convert integrin aLb2 to an extended
but low-affinity conformation that slows rolling velocities. Signaling through
G protein-coupled chemokine receptors activates integrins to an extended and
high-affinity conformation that mediates arrest. These signaling pathways
cooperate to maximize neutrophil recruitment to sites of inflammation.
Dysregulated leukocyte adhesion contributes to inflammatory tissue damage
in common diseases.
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S02-3
COAgULOPATHy OF SEPSIS: VIEW FROM THE BEDSIDE
Gary T. Kinasewitz
Pulmonary/Critical Care,
University of Oklahoma School of Medicine, Oklahoma, USA
Gary-Kinasewitz@ouhsc.edu
Virtually all patients with severe sepsis develop a coagulopathy irrespective
of the underlying organism and site of infection.  To quantitate the
coagulopathy we developed a simple evolving DIC score based on the absolute
value and change in platelet count and prothrombin time (PT), and applied it
to 403 prospectively identified ICU patients with severe sepsis.  Patients were
clinically classified as having capillary leak syndrome (n=39), persistent
multiorgan failure with death (n=97) or survival (n=126) or transient organ
failure (n=141) if they showed rapid improvement in their MODS score.  .
The simple evolving DIC score increased with worsening clinical class and
was associated with worsening organ failure.  Mortality increased from 7%
for a simple evolving score of 0 to 74% for a score of 4 (P < 0.01).  Overall,
87% of those with a score ≤ 1 survived while a majority of those with a score
≥ 2 developed multiorgan failure and 55% died from sepsis.  Thus, the simple
evolving DIC score which can be calculated at the bedside from 2 readily
available global coagulation markers appears to reflect the severity of the
underlying disorder, and provides useful prognostic information for the patient
with severe sepsis.
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S02-4
PATHOPHySIOLOgy, STAgINg AND THERAPy OF SEVERE
SEPSIS
Florea Lupu 
Oklahoma Medical Research Foundation, Oklahoma City, USA
florea-lupu@cox.net 
Severe sepsis is a multi-stage, multi-factorial and life-threatening condition
that arises when the innate response of the body to infection injures its own
tissues and organs. Patients with severe sepsis can develop a fulminate form
of the disease and die within hours with massive disseminated intravascular
coagulation (DIC) and cardiovascular collapse, or may develop a protracted
organ failure that may lead to delayed death despite supportive therapy. The
disease passes through an initial inflammatory/coagulopathic stage triggered
by the pathogen, followed by a second stage, driven by ischemia/reperfusion
(IR) and oxidative stress. Since rodent models do not accurately replicate this
complex pathophysiology we have developed and characterized primate
models that mimic the two clinical variants. The model of refractory
hypotension and consumptive coagulopathy was used in the development of
activated protein C for the treatment of sepsis. The model of persistent multi-
organ failure allowed us to identify the histone/nucleosome release and
uncontrolled complement activation as major amplifying loops of the initial
injury produced by IR/oxidative stress. Currently, we are developing
approaches to block the harmful effects of complement activation products
and extracellular histones/DNA during the organ failure stage of severe sepsis
as potential therapeutic strategy.
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S02-5
REgULATION OF TISSUE FACTOR DEPENDENT
COAgULATION
Cristina Lupu
Oklahoma Medical Research Foundatio, Oklahoma City, USA
Cristina-Lupu@omrf.org
The tissue factor (TF) pathway triggers blood coagulation. TF is essential for
hemostasis, but aberrant expression and activation of TF by monocytes,
neutrophils, endothelial cells (EC), and platelets likely contribute to thrombotic
complications in various diseases including, but not limited to, cardiovascular
disease, diabetes, cancer and sepsis. The major physiological, Kunitz-type
regulator Tissue Factor Pathway Inhibitor (TFPI) inhibits the activity of TF-
Factor VIIa complex in a Factor Xa-dependent manner, thus controlling the
generation of thrombin and ultimately, fibrin. TFPI is constitutively produced
by EC, within which locates in lipid rafts/caveolae via a GPI-linkage, a
property that confers major anticoagulant functions to the cell-associated forms
of TFPI as opposed to the soluble truncated forms of the inhibitor. The proper
regulation of TF activity is critical for maintenance of the hemostatic balance.
In septic baboons, increased TF-dependent procoagulant activity is partly due
to decreased lung-associated TFPI, as well as focal up-regulation of TF
concurrently with reduced TFPI within arterial branching areas. Finding ways
to up-regulate the cell-associated TFPI to prevent unwanted clotting and to
inhibit TF-dependent pathological effects is a still under-investigated area. A
newly discovered protein, ADTRP, which regulates TFPI expression and
function in EC androgen-dependently, could be instrumental for the design of
vascular protection strategies to counteract thrombosis. 
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S-03 Symposium 
“Advances in stroke”
Chaired by: N. Bornstein, W.-D. Heiss
Date: Saturday, June 9th
Starting time: 08:30 
Location: Hall A (Rapsodia)
1. N. Bornstein
Secondary stroke prevention
2. W.-D. Heiss
Imaging the penumbra: the pathophysiologic basis for
therapy of ischemic stroke
3. Antonio Federico
Small vessel inherited diseases: clinical and molecular
findings
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S03-1
SECONDARy STROKE PREVENTION
Natan Bornstein
Stroke Unit, Dept. of Neurology, Sackler School of Medicine, 
Tel-Aviv University, Tel-Aviv, Israel
natanb@tasmc.health.gov.il 
Patients with TIA or ischemic stroke carry a risk of recurrent stroke between
5 and 20% per year. In patients with TIA or ischemic stroke of noncardiac
origin antiplatelet drugs are able to decrease the risk of stroke by 11-15% and
the risk of stroke, MI and vascular death by 15-22%. Aspirin is the most widely
used drug. It is affordable and effective. Low doses of 50-325 mg aspirin are
as effective as high doses and cause less gastrointestinal side effects. Severe
bleeding complications are dose-dependent. The combination of aspirin with
slow release dipyridamole is superior to aspirin alone for stroke prevention
(ESPS-2 and ESPRIT). Both studies have shown approximately 20%-24%
relative risk reduction (RRR) of stroke and death. Clopidgrel is superior to
aspirin in patients at high risk of recurrence by about 8.7% RRR (CAPRIE).
The combination of aspirin plus clopidogrel is not more effective than
clopidogrel alone but carries a higher bleeding risk (MATCH and
CHARISMA). None of the antiplatelet agents is able to significantly reduce
mortality. The recent results of the PRoFESS trial showed no difference
between clopidogrel and aspirin with slow release dipyridamole in secondary
stroke prevention. 
32
S03-2
IMAgINg THE PENUMBRA: THE PATHOPHySIOLOgIC BASIS
FOR THERAPy OF ISCHEMIC STROKE
Wolf-Dieter Heiss
Max Planck Institute for Neurological Research, Cologne, Germany
wdh@nf.mpg.de
The ischemic penumbra defines the perfusion range between the thresholds
for functional impairment and irreversible tissue damage. The translation of
this experimental concept as the basis for efficient treatment of stroke requires
non-invasive methods by which regional flow and energy metabolism can be
repeatedly investigated. Positron emission tomography (PET) allows the
quantification of cerebral blood flow,  metabolic rate for oxygen and oxygen
extraction fraction. By these variables a clear definition of irreversible tissue
damage and of critically perfused but potentially salvageable tissue (i.e. the
penumbra) can be achieved. Further tracers can be used for early detection of
irreversible tissue damage (central benzodiazepine receptor ligand flumazenil)
and of microglia activation (translocator protein ligand). As a widely
applicable clinical tool perfusion/diffusion weighted magnetic resonance
imaging is used, and the “mismatch” between the PW- and the DW-
abnormalities might serve as an indicator of the penumbra, but has limitations.
Based on the concept of the penumbra improvement of perfusion within the
time window of opportunity must be the primary goal in treatment of ischemic
stroke, and neuroprotective and other strategies can only play a supportive
role. By detecting the pathophysiological state of the tissue PET can help in
the development of efficient treatment strategies.
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S03-3
SMALL VESSEL INHERITED DISEASES: 
CLINICAL AND MOLECULAR FINDINgS
Antonio Federico
Dept. Neurological, Neurosurgical and Behavioural Sciences, 
Medical School, University of Siena, Siena, Italy
federico@unisi.it
Advances in molecular genetics lead to identification of several monogenic
conditions involving small vessels and predisposing to ischaemic and
haemorrhagic strokes and diffuse white matter disease. Cerebral
microangiopathies constitute an appreciable portion of all strokes. In middle
aged patients, hereditary cerebral small vessel diseases have to be separated
from sporadic degenerative cerebral microangiopathy which is mainly due to
a high vascular risk load. Features of the following disorders and details for
there are here reviewed, namely Cerebral Autosomal Dominant Arteriopathy
with Subcortical Infarcts and Leukoencephalopathy (CADASIL), Cerebral
Autosomal Recessive Arteriopathy with Subcortical Infarcts and
Leukoencephalophaty (CARASIL), COL4A1-related cerebral small vessel
diseases, Autosomal Dominant Retinal Vasculopathy with leuco dystrophy
(AD-RVLC) and neurometabolic diseases such as MELAS and FABRY. The
hereditary SVDs albeit with variable phenotypes demonstrate how effects of
different defective genes converge to produce the characteristic arteriopathy
and microvascular disintegration leading to vascular cognitive impairment.We
describe also our experience in Siena, in the diagnosis, research and treatment
of these diseases.
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“Multimodal molecules in neuroprotection
and neurorecovery treatment”
Chaired by: A. Alvarez, D.F. Mureşanu
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Starting time: 14:30 
Location: Hall A (Rapsodia)
1. D.F. Mureşanu
Towards a unified theory in brain damage and recovery
2. A. Alvarez
Multimodal molecules with pleiotropic neuroprotective in
brain protection and recovery
3. A. Cedazo-Minguez
Neurotrophic factors in CNS biology
4. Mihaela Băciuţ
Regeneration of the peripheral nerve - the maxillo-facial
surgeon’s view
5. Chung-Hsin Wu
Adaptive mechanisms of hypothermic neuroprotection in
Taiwan leaf-nosed bat
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S04-1
TOWARDS A UNIFIED THEORy IN BRAIN DAMAgE AND
RECOVERy
Dafin F. Mureşanu
Department of Clinical Neurosciences
“Iuliu Hatieganu” University of Medicine and Pharmacy
Cluj -Napoca, Romania
dafinm@ssnn.ro 
Neurotrophicity, neuroprotection, neuroplasticity and neurogenesis are basic
biological processes of paramount importance, overlapping and acting under
genetic control to generate the endogenous defense activity (EDA) which
continually counteracts pathophysiological processes.
Pathophysiological processes share common mechanisms with endogenous
basic biological processes (e.g. excitotoxicity and neurotrophicity together
with neuroplasticity have, as a common important driver, the NMDAR
activity; inflammation has an important contribution for neuroregeneration,
stimulating neuroplasticity, via trophic factors).
Every lesion in the nervous system triggers in the first minutes an endogenous
neuroprotective reaction. An endogenous repair process, combining
neuroplasticity and neurogenesis follow this as a second answer. All these
processes are initiated and regulated by neurotrophic factors. The same
molecules, due to a complex genetically regulated process, are able to induce,
immediately after achieving the endogenous neuroprotective effect,
neuroplasticity and neurogenesis as well. Therefore, they have also not only
pleotropic activity but also multimodal way.
Neuroprotection, neuroplasticity and neurogenesis, processes that are
apparently independent, with different control, represent in fact sequences of
the same process (EDA), regulated by neurotrophic factors.
Considering this, neurotrophic factors are important therapeutic agents in most
important neurological disorders, including stroke and there are many positive
clinical data proving this.
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S04-2
MULTIMODAL MOLECULES WITH PLEIOTROPIC
NEUROPROTECTIVE IN BRAIN PROTECTION AND RECOVERy
Antón Alvarez
Research Directorate, Antidementia Al-Andalus Foundation, 
A Coruña, Spain
xantonal@yahoo.es
Neuronal degeneration is a common feature that can be triggered by different
mechanisms in medical conditions such as traumatic brain injury,
cerebrovascular disorders and Alzheimer’s disease. The pathology of these
central nervous system disorders is very complex and involves several
common pathogenic processes, including excitotoxicity, inflammation,
oxidative damage, apoptosis, neurodegeneration and neurotrophic alterations.
Glutamate, calcium-calpain, pro-inflammatory cytokines such as tumor
necrosis factor-alpha (TNF-α), reactive oxygen species, amyloid and tau
proteins, neurotrophic factors like BDNF (brain-derived neurotrophic factor),
IGF-I (insulin-like growth factor) or VEGF (vascular endothelial growth
factor), and signaling proteins including kinases such as Akt (serine/threonine
protein kinase), GSK3β (glycogen synthase kinase-3 beta) and CDK5 (cyclin-
dependent kinase 5) are key molecules contributing to mechanisms of neuronal
degeneration, protection and recovery.
Neuroprotection and recovery of neuronal damage are priority goals in the
treatment of the aforementioned pathological conditions. Since there is no
disease-modifying treatment so far for these disorders, the development of
multimodal drugs able to act on different molecular targets constitutes a
promissing therapeutic alternative. The multimodal effects of neurotrophic
factors, erythropoietin, statins or Cerebrolysin, a peptidergic compound
mimicking the activity of endogenous neurotrophic factors, were investigated
in different experimental models of stroke, Alzheimer’s disease and traumatic
brain injury with positive results. Clinical studies also support the efficay of
such an intervention in improving symptoms and/or the clinical recovery of
patients affected by these disorders.
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S04-3
NEUROTROPHIC FACTORS IN CNS BIOLOgy  
Angel Cedazo-Minguez
Karolinska Institutet, NVS Department
KI-Alzheimer’s Disease Research Center
Stockholm, Sweden
Angel.Cedazo-Minguez@ki.se
Neurotrophic factors are considered as molecular mediators of synaptic
plasticity, neurite outgrowth, neuronal cell differentiation and survival.
Reduced levels and activities of neurotrophic factors, such as nerve growth
factor (NGF) or brain-derived neurotrophic factor (BDNF), have been
described in a number of neurodegenerative disorders, including Alzheimer’s
disease (AD). The concept of increasing the expression/activity or,
alternatively, the restorative administration of these endogenous protective
systems may offer promising therapeutic alternatives. However, while the
therapeutic potential of neurotrophic factors has been well-recognized, the
translation to the clinic has been disappointing, mostly due to considerable
delivery obstacles.
This presentation will briefly review recent findings linking defects in NGF
and BDNF to AD pathogenesis, as well as data from preclinical and clinical
studies exploring their potential therapeutic possibilities for AD.
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S04-4
REgENERATION OF THE PERIPHERAL NERVE – 
THE MAxILLO-FACIAL SURgEON’S VIEW
Mihaela Băciuţ1, Dafin Mureşanu2, Grigore Băciuţ3
1 Clinic of Maxillofacial Surgery and Implantology, 2 Department of
Neurosciences, 3 Clinic of Cranio-Maxillofacial Surgery, 
“Iuliu Haţieganu” University of Medicine and Pharmacy, 
Cluj-Napoca, Romania
mbaciut@yahoo.com
Surgical procedures performed in maxillofacial surgery imply dissection in
the immediate vicinity of sensitive (trigeminal nerve) and motor (facial nerve)
branches. A large range of procedures in this field can affect the nerve function
postoperatively, spreading over a period of time which seriously influences
the life quality of the patient. 
Postoperative deterioration of the nerve function can be noticed frequently
and is produced by multiple mechanisms. 
Direct intraoperative trauma of various degrees, ranging from blunt contusion
to laceration, compression by postoperative edema, seroma, hematoma or bone
fragments are the most frequently incriminated causes of nervous dysfunction.
Orthognathic surgery is performed increasingly. It implies osteotomies of the
maxillary bones to correct their position and/or dimension in cases of
maxillofacial deformities. The osteotomy lines of the mandible split the bone
through the mandibular canal. 
In the postoperative period, anesthesia of various degrees of the lower hemilip
and –chin can be noticed and evaluated. Healing is monitored during the
follow-up interval and is supposed to imply multiple mechanisms as well. 
In order to support the healing, antiinflammatory drugs of different categories
and vitamins are administered routinely according to various protocols. Their
action is controversial when considering the various regeneration mechanisms.
In this regard, healing should be supported with drugs of different categories. 
The present study intended to evaluate and discuss the regenerative
neurological capacity in patients having undergone maxillofacial surgery
procedures.
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S04-5
ADAPTIVE MECHANISMS OF HyPOTHERMIC
NEUROPROTECTION IN TAIWAN LEAF-NOSED BAT
Chung-Hsin Wu
Department of Life Science, National Taiwan Normal University,
Taipei, Taiwan 
megawu@ntnu.edu.tw 
Hibernation is one of the most fascinating strategies for some animals to
survive when environmental temperature is very low and food resources are
scarce or absent, furthermore, this kind of the prolonged bouts of torpor can
be interrupted periodically by spontaneously brief arousals. In order to go
through the harsh conditions, hibernating animals change to an inactive state
by strongly suppressing metabolic rate and lowering body temperature to
around 0 °C. Suppression of metabolic rate is mainly reflected by reduced
heart beat and respiratory rates. It is attractive that why hibernators can survive
in the situation of frequent and dramatic fluctuations of body temperature and
blood flow without neurological damage. In this study, we investigated
hematocrit (Hct) and blood glucose concentration in capillary blood at room
temperature (25°C) and during hibernation (0°C) in Taiwan leaf-nosed bat
(Hipposideros terasensis). The data suggested that natural up-regulation of
Hct and blood glucose concentration during hibernation in Taiwan leaf-nosed
bat play role in hypothermic neuroprotective mechanisms. Also, Our data
showed that suppression of free radical production and of excitotoxin release
may contribute to protection when cooling is started during hypoxia ischemia. 
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S-05 Symposium
“The management of early and late
Parkinson’s disease”
Chaired by: A. Antonini, O. Băjenaru
Date: Saturday, June 9th
Starting time: 12:00 
Location: Hall A (Rapsodia)
1. Regina Katzenschlager
Non-invasive treatment options for motor complications
in Parkinson’s disease
2. A. Antonini
The role of Apomorphine in the treatment of Parkinson’s
disease
3. O. Băjenaru
Interventional treatment of continuous dopaminergic
stimulation in advance Parkinson’s disease
4. Tarek Tawfik
Future strategies in Parkinson’s disease treatment
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S05-1
NON-INVASIVE TREATMENT OPTIONS FOR MOTOR
COMPLICATIONS IN PARKINSON’S DISEASE
Regina Katzenschlager
Neurologische Abteilung, Donauspital / SMZ-Ost, Vienna, Austria
regina.katzenschlager@chello.at
Dopaminergic replacement therapy is usually very effective in relieving the
motor symptoms of Parkinson’s disease. However, the majority of patients
develop motor complications following longer-term treatment. Risk factors
include the rate of neuronal loss, younger age at disease onset, high L-dopa
dose and initial treatment with short-acting drugs. 
Motor fluctuations (ON/OFF fluctuations) can often be ameliorated by
adapting the intervals and doses of individual L-DOPA doses, by blocking
dopamine degradation using monoamino (MAO)-B inhibitors and catechol-
O-methyl transferase (COMT) inhibitors, or by adding dopamine agonists
orally or transdermally. In addition, advising patients on the potential impact
of meal times on drug absorption is often useful. Dispersible formulations of
L-dopa may provide faster relief from OFFs.
In those patients where dyskinesias have developed, treatment options often
become limited as dose increases may worsen dyskinesias and decreases may
worsen motor function and OFF duration. Amantadine is the only oral drug
that has been demonstrated to improve dyskinesias without worsening
parkinsonism but the effect size is limited and tolerability may be a concern.
When all adaptations of oral and transdermal drugs have been exhausted,
invasive or device-aided options such as pump treatments and deep brain
stimulation should be considered for eligible patients.
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S05-2
THE ROLE OF APOMORPHINE IN THE TREATMENT OF
PARKINSON’S DISEASE
Angelo Antonini
Parkinson Unit, IRCCS San Camillo, Venice – Neurology Clinic,
University of Padua, Italy
angelo3000@yahoo.com
Apomorphine is the oldest dopaminergic medication and was initially known
for its emetic properties. It was initially used for Parkinson’s disease over 60
years ago but later ignored for many years following levodopa introduction.
It is also the most potent dopamine agonist and its administration can provide
symptom relief comparable to levodopa. Apomorphine exerts its
antiparkinsonian effect by direct stimulation of striatal postsynaptic dopamine
D1 and D2 receptors. The drug has a rapid absorption after subcutaneous
injection (Cmax 20 min), and a short half-life (almost 43 min), and this is
consistent with its rapid onset of action, with effects apparent within 5–15
minutes of subcutaneous administration. Clinical studies and evidence-based
reviews generally support a role for apomorphine infusion as an effective
option for patients with PD and severe fluctuations, poorly controlled by
conventional oral drug treatment with an improvement in OFF-time between
50% and 80% as well as dyskinesia. While the benefit on off time is consistent
across all studies, dyskinesia improvement generally occurs after a few weeks
or months of continuous dopaminergic stimulation as a result of wider
therapeutic window. Moreover it can be best achieved with apomorphine
monotherapy that may require high infusion doses. 
Intermittent subcutaneous apomorphine (penjet) may instead be suitable for
the long-term acute treatment of OFF episodes in patients with advanced PD.
Apomorphine injections can be a particularly helpful in the management of
patients who undergo surgical procedures and cannot take medication by
mouth or to treat additional severe non-motor symptoms occurring during OFF
periods.
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S05-3
INTERVENTIONAL TREATMENT OF CONTINUOUS
DOPAMINERgIC STIMULATION IN ADVANCE PARKINSON’S
DISEASE
Ovidiu Băjenaru
“Carol Davila” University of Medicine and Pharmacy Bucharest, Romania 
ovalbajenaru@yahoo.com
Parkinson’s disease (PD) is a progressive multifocal neurodegenerative disease
characterised by multiple synaptic dysfunctions which clinical impact impairs
motor behaviour, sensory, neurocognitive,  autonomic functions, sleep, mood
and other components of human behaviour. Among these, motor dysfunction
is one of the most important factors which impairs patients’ daily life activity
and quality and the best studied due to its relation to disturbed dopaminergic
modulation in the cortico-striatal circuits (even if in these patients also
dysfunctions of other structures of the brain - not always related to dopamine
modulation - impair the motor behaviour ). In advanced stages of the disease
these clinical impairments are enhanced in symptomaticaly treated patients by
the dopaminergic agents, in particular oral levodopa leading to motor and non-
motor complications. These treatment complications are mostly related to the
non-physiologic pulsatile stimulation by oral drug administration which are
oposed to the tonic, continuous, physiologic dopaminergic synaptic
modulation of the indirect striopallidal pathway and probably also of the non-
synaptic modulation of neuronal intracellular signaling pathways related to
neuroplasticity. In advanced Parkinson’s disease in patients whom
symptomatic control of their clinical manifestations cannot be obtained any
more with the best oral drugs combinations, particular therapeutic approaches
are available today. Among these, continuous levodopa administration by an
electronic pump directly in the jejunum using a transcutaneous laparoscopic
gastrostoma using a special tubular device or deep brain stimulation with a
high frequency from an electronic stimulator using a special electrode system
stereotaxically inserted bilateraly in the subthalamic nucleus (or in the internal
part of the globus pallidus) are common nowadays. We shall present also our
personal clinical experience using these methods in the Department of
Neurology of the University Emergency Hospital Bucharest.
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S05-4
FUTURE STRATEgIES IN PARKINSON’S DISEASE TREATMENT
Tarek Tawfik
Cairo University, Cairo, Egypt
Considerable advances have been made in defining the aetiology,
pathogenesis, and pathology of PD and these advances in turn have resulted
in development and rapid expansion of the pharmacopoeia available for
treatment. However, treatment remains unsatisfactory, as it mainly addresses
only the dopaminergic features of the disease and leaves its progressive course
unaffected. The future of PD drug treatment will need to focus on the
symptomatic management of the non-dopaminergic and non-motor features
of the disease and on the need of disease modification on terms of delay or
prevention of progression.
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functions
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Myocardial connexin-43 is implicated in adaptation and
maladaptation to hypertension as well as in
cardioprotective effects of the treatment
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S06-1
A PAUSE FOR THOUgHT – WHAT ARE THEy KEy ADVANTAgES
AND DISADVANTAgES OF RODENT MODELS OF HUMAN
PREgNANCy AND PRETERM LABOUR?
Michael J. Taggart
Institute of Cellular Medicine, Newcastle University, UK.
michael.taggart@newcastle.ac.uk
Preterm birth (PTB) has profound detrimental effects for a healthy life. It’s
the largest contributor to deaths in children under 1 year of age, causes 75%
of all neonatal intensive care admissions and those children who do survive
are at increased risk of lifelong debilitating mental and physical health.  To
improve our understanding of the biology of parturition and,  in concert,
develop new drugs and drug delivery strategies to treat PTB, we must consider
the use of appropriate non-primate models. Rat and mouse (including
knockouts) models of pregnancy have been instrumental in improving our
understanding of the cellular and tissue mechanisms of uterine activation
accompanying labour at term and preterm.  However, a marked difference
between these rodents and humans is that parturition in the former, but not
humans, is precipitated by a marked fall in maternal serum progesterone.
Attention has recently returned to considering the benefits of the guinea pig
as an additional rodent model of human parturition as serum progesterone
withdrawal does not appear to be a pre-requisite for labour onset in this
species.  Therefore, we analyse whether rigorous cross-species bioinformatic
and functional comparisons offer the best opportunity for advancing our
understanding of the complexity of parturition and PTB. 
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S06-2
AgE-RELATED CHANgES IN CARDIOVASCULAR RESPONSES
TO LOWER BODy POSITIVE PRESSURE ON DURINg WALKINg
IN WOMEN
Satoshi Matsuo1
Takeshi Sota2, Yukiko Okada2, Hiroshi Hagino2, Yasuaki Kawai1
1Department of Adaptation Physiology, Faculty of Medicine, Tottori
University,  2Department of Rehabilitation, Tottori University Hospital.
smatsuo@med.tottori-u.ac.jp
We investigated the effects of lower body positive pressure (LBPP) on
cardiovascular responses during a 15-min walking in young and elderly
women. The application of 20 mmHg LBPP reduced ground reaction forces
by 31.2 ± 0.5 kgw in both groups. We hypothesized that cardiovascular
responses to LBPP during walking were different between the young and
elderly subjects.
Applying 20 mmHg of LBPP increased diastolic pressure in both subjects
(young: 2 ± 1 mmHg, elderly: 2 ± 1 mmHg). Applying LBPP also increased
mean blood pressure (MBP) in elderly subjects (2 ± 1 mmHg) but not in young
subjects. After the application of LBPP, MBP decreased in both subjects
(young: 3 ± 1 mmHg, elderly: 3 ± 1 mmHg). LBPP reduced heart rate (HR)
during walking in both groups, however the reduction in HR occurred more
quickly in the young group compared to the elderly group. Applying LBPP
also decreased double product (HR × systolic blood pressure) during walking
in both groups, suggesting that LBPP reduces myocardial oxygen consumption
during exercise. These results suggest that cardiovascular responses to LBPP
during walking could change with aging.
49
S06-3
MyOCARDIAL CONNExIN-43 IS IMPLICATED IN ADAPTATION
AND MALADAPTATION TO HyPERTENSION AS WELL AS 
IN CARDIOPROTECTIVE EFFECTS OF THE TREATMENT
Narcisa Tribulova 1
Radosinska J. 2, Bacova B. 1, Benova T. 1, Vinczenczova C. 3, 
Knezl V. 4, Slezak J. 1
1Institute for Heart Research,, SAS, Bratislava, Slovakia, 
2Inst. Physiology, Med. Fac. Comenius University, 3Faculty of Natural
Sciences of Comenius University, 4Institute of Experimental Pharmacology
& Toxicology, SAS, Bratislava, Slovakia
usrdtri@savba.sk
Intercellular gap junction connexin (Cx) channels are important determinants
of myocardial conduction and synchronization crucial for heart function.
Hypertension-induced structural remodeling in humans is associated with an
increased risk of life-threatening cardiac arrhythmias and heart failure. Using
immunohistochemistry, electron microscopy, western blotting and real time
PCR we have found that altered distribution (lateralization) and down-
regulation of Cx43 in spontaneously hypertensive (SHR) were linked with
increased propensity to ventricular fibrillation (VF) comparing to age-matched
normotensive rats. In contrast, long-term treatment of SHR with either omega-
3 fatty acids or antioxidant rich red palm oil resulted in attenuation of
myocardial structural and Cx43 remodeling. In addition, the treatment
increased expression of Cx43 mRNA or Cx43 protein as well as its functional
phosphorylated forms. Consequently, there was a significant suppression of
VF incidence in treated SHR. We conclude that abnormal myocardial Cx43
distribution and expression due to cardiac adaptation to hypertension may
contribute to increased propensity to malignant arrhythmias. On the other
hand, attenuation of hypertension-related myocardial Cx43 abnormalities by
treatment with omega-3 fatty acids or red palm oil confers protection from
malignant arrhythmias.
This study was supported by VEGA 0046/12 and APVV SK-CZ-0027-11
grants. 
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S07-1
CHALLENgES IN THE NEUROPATHOLOgIC DIAgNOSIS OF
DEMENTIAS
Kurt A. Jellinger 
Institute of Clincal Neurobiology, Vienna, Austria
kurt.jellinger@univie.ac.at 
Dementia, defined as deterioration in several cognitive domains, is a major
public health problem. It is not only caused by neuronal cell death but
particularly by dysfunction/loss of synapses causing default neuronal
networks. Consensus criteria for the clinical and neuropathologic diagnosis of
different dementia disorders have recently been updated. Morphologic
assessment, using immunohistochemistry, molecular biologic and genetic
methods can achieve a diagnosis/classification, based on homogenous
definitions, harmonized inter-laboratory methods and assessment standards,
in almost 99%, without, however, clarifying the etiology of most of these
diseases. The new Aging-Alzheimer Association guidelines combine Aβ
plaque phases, Braak NFT and CERAD neuritic plaques scores, also
considering cerebrovascular disease, Lewy body and other pathologies.
However, due to considerable overlap between many dementing disorders, in
particular neurodegenerative proteinopathies, studies in human subjects with
autopsy confirmation entail numerous biases that affect both their general
applicability and the validity of correlations. Further difficulties arise from
recent separation of distinct clinicopathologic subtypes (“tangle-intensive”
and “plaque-intensive”) from classical Alzheimer disease. Although most
neurodegenerative dementing disorders are incurable at present, concerted
prospective clinicopathologic studies using validated protocols and data fusion
are required to overcome the limitations of the current diagnostic framework
as a basis for efficient new therapy options.
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S07-2
MICROTUBULES AND BRAIN PROTECTION: DAVUNETIDE
Illana Gozes, Oz S
Department of Human Molecular Genetics and Biochemistry,
School of Neuroscience, Sackler Faculty of Medicine,
The Adams Super Center for Brain Studies, Tel Aviv University, Israel
igozes@post.tau.ac.il 
Davunetide (NAPVSIPQ; NAP), a neuroprotective peptide that we derived
from activity-dependent neuroprotective protein (ADNP), provides protection
against ADNP haploinsufficiency. NAP enhances cognitive function,
protecting the microtubule network and reducing tau pathology in models of
Alzheimer’s disease and related tauopathies.  We recently found that NAP
treatment significantly affected the microtubule tyrosination cycle which is
associated with microtubule dynamics in the living cell. This effect was
coupled to increased microtubule network area which is directly related to
neurite outgrowth. Expression of the microtubule subunit, tubulin beta III, a
marker for neuronal differentiation and neurite outgrowth, increased as a
consequence of NAP treatment. Measurements of microtubule remodeling in
cultured neurons suggests an effect of NAP that increases dynamic Tyr-tubulin
compared to control. Finally, high zinc concentrations induce microtubule
breakdown and tubulin subunit toxic aggregation but this cellular toxicity was
reversed by NAP treatment. Davunetide (NAP) is currently in Phase II/III
clinical trial in progressive supranuclear palsy a disease presenting tauopathy
(Allon Therapeutics Inc.). Activity in this trial should pave the path to other
tauopathies/disease associated with microtubule dysfunction.
Acknowledgements: Gildor Chair, Adams Super Center, Elton Lab., AMN,
CFTAU, Allon Therapeutics Inc.
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S07-3
THE PHILOSOPHy OF DEMENTIA
Stavros J. Baloyannis
Aristotelian University, Thessaloniki, Greece
sibh844@otenet.gr
Understanding the fundamental nature of mind, from the philosophical
viewpoint, became the main subject of the neurophilosophy. Dementias attract
reasonably the attention of philosophers, who search for an explanation of
mental decline. Although the morphological and functional alterations may
interpret the drama of dementia, however they cannot approach the question
of the condition of the self in dementia. The memory loss detach obviously
the self from the past and isolate it in the present. However, we do not know
the dimensions of the interior aspect of time in  dementia, which play an
important role in the  duration and integration of the self. Νeuropsychology
reveals that demented persons, can retain their identity and the activity and
character of their interior life, which is depended on the existential dimensions
of the self. The insight of the mental tragedy in dementia is an evidence of an
active interior life. The concept of the good and evil, the dignity and the self
respect may be unaffected by the loss of memory. A detailed analysis of the
interior life and the existential dimensions of the individual may be required
for assessing the continuation of the self and the integrity of the Being in
dementias.
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S08-1
OBESITy, A gLOBAL EPIDEMIC
Gabriela Roman
“Iuliu Haţieganu” University of Pharmacy and Medicine, 
Clinical Center of Diabetes, Nutrition, Metabolic diseases, 
Cluj-Napoca, Romania
groman@umfcluj.ro
Obesity is now recognised as a global epidemic and the most prevalent
metabolic disease world-wide. Despite significant recent research investment,
obesity prevalence rates continue to rise throughout most countries of the
world. Last IASO analysis (2010) estimates that approximately 1 billion adults
are currently overweight (BMI 25-29.9 Kg/m²), and a further 475 million are
obese.  When Asian-specific cut-off points for the definition of obesity (body
mass index >28 kg/m²) are taken into account, the number of adults considered
obese globally is over 600 million. Children are affected as well, up to 200
million school aged children are either overweight or obese, of those 40-50
million are classified as obese. In Europe, approximately 60% of adults (260
million) and over 20% of school-age children (over 12 million) are overweight
or obese.  The great challenge of obesity is the high risk for type 2 diabetes,
cardiovascular diseases and cancer. The disease therefore incurs an
increasingly heavy burden not only on overweight and obese citizens
themselves but also on health care systems, the efficiency of the workforce
and society at large. Prevention of obesity and weight gain at high risk
population level is the main strategy to reduce the burden of obesity. 
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S08-2
OBESITy, gENDER AND CORONARy HEART DISEASE
Raffaele Bugiardini
University Alma Mater of Bologna, Bologna, Italy
raffaele.bugiardini@unibo.it 
We examined the influence of relative weight at early stages of the life
(30.6±5.9 years) on endothelial function and vascular structure of healthy
subjects without traditional risk factors and family history of coronary artery
disease (CAD). We also explored the importance of controlling for Glu298Asp
polymorphism in the assessment of the effect of weight, as well as possible
interrelations of weight with gender.
Subjects were grouped as Glu homozygotes and Asp carriers. In women, Asp-
carriers had a significantly lower endothelial function (as assessed by flow
mediated dilation; FMD) and greater intima-media thickening (IMT) than
Glu298-homozygotes. In men, there was no difference in both FMD and IMT
between Asp-carriers and Glu298-homozygotes. A higher body mass index
(BMI) was positively associated with lower FMD and greater IMT in Asp
carriers, but not in Glu homozygotes. As expected, control for systolic blood
pressure a condition known to be related to weight, attenuated the strength of
the association.
These data emphasize the importance of weight as a determinant of CAD in
women. Even mild-to-moderate overweight increased the risk of sub- clinical
atherosclerosis in young healthy women. The eNOS Glu(298)/Asp
polymorphism may contribute to these sex related differences in the effect of
weight.
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S08-3
ABDOMINAL OBESITy AND INFLAMMATION
Marius Vintilă, M. Băluţă
“Carol Davila” University of Medicine and Pharmacy
St. Pantelimon Universitary Emergency Hospital, Cardiology Department,
Bucharest, Romania
mmvintila@yahoo.com
Abdominal obesity is associated to chronic low-grade inflammation
originating from expanding fat tissue. Cross-sectional studies have shown a
relationship between adiposity and circulating markers of inflammation. 
Adipose tissue is a source of proinflammatory cytokines. Abdominal fat tissue
and resident macrophages within this tissue seem to be the primary source of
cytokines such as interleukin-6 (IL-6) or tumor necrosis factor-α. These
promote inflammation and shift the activation state of adipose tissue
macrophages to a proinflammatory phenotype. IL-6 secretion directly might
induce the production of CRP in the liver. Adipose tissue-resident
macrophages appear to be also the primary source of IL-1F6. IL-1F6 is a new
member of the IL-1 family of cytokines that display proinflammatory effects. 
Regulatory T cells may play also a critical role as determinants of adipose
inflammation. They inversely correlated with CD11b+ and CD11c+ adipose
tissue macrophages (ATMs). Human visceral fat in morbid obesity was
characterized by an increase in CD11c+ ATMs. 
Adipose tissue itself is a source and site of inflammation. 
Inflammatory markers such as IL-6, TNF-α and adipokines (resistin,
adiponectin) are associated with metabolic alterations. Whether obesity “per
se” or rather the associated inflammation determine the cardiometabolic risk
need to be determined.
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S08-4
CORONARy VASCULAR TONE AND OBESITy
Akos Koller 1, 2
1Department of Pathophysiology and Gerontology, University of Pécs, 
Pécs, Hungary
2Department of Physiology, New York Medical College, Valhalla, NY, USA
akos.koller@aok.pte.hu 
Vasomotor adaptation and/or dysfunction of the coronary microvessels is
considered to be one of the early developing alterations in obesity, contributing
to the disturbed regulation of coronary perfusion. The existence of vascular
adaptive mechanisms in coronary vessels was shown by several recent studies.
We have found that dilations to acetylcholine (ACh) were not significantly
different in obese and lean rats, yet the inhibition of nitric oxide (NO) synthesis
reduced ACh-induced dilations only in vessels of lean controls. The presence
of the soluble guanylate cyclase (sGC) inhibitor elicited a similar reduction
in ACh-induced dilations in the two groups of vessels. Dilations to the NO
donor were enhanced in coronary arterioles of obese compared with lean
control rats. Moreover, NO donor-stimulated cGMP immunoreactivity in
coronary arterioles and also cGMP levels in carotid arteries were enhanced in
obese rats, whereas the protein expression of endothelial NOS and the sGC
beta1-subunit were not different in the two groups. In Zucker obese rats others
found a reduced ET-1-induced constriction of coronary arteries, due to
increased ET(B)-mediated generation of NO and diminished elevation of
myoplasmic [Ca2+]i. Thus obesity has a complex effect on the vasomotor
regulation of coronary microvessels. 
AHA FA 0855910D, Hungarian Sci. Res Fund.-OTKA K71591.
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S08-5
INTRAVASCULAR INTERVENTIONS IN OBESE PATIENTS
Şerban Bălănescu
Bucharest Emergency Hospital, Romania
SMBALA99@hotmail.com
Obesity induces accelerated atherosclerosis and increased cardiovascular risk
by atherothrombotic events. Despite multiple mechanisms that may be kept
responsible for negative prognosis in these patients (pts), long term follow-up
data suggested that a so-called “obesity paradox” might exist. This is defined
by a paradoxical decrease in mortality with increasing body mass index (BMI)
in pts with cardiovascular disease. 
Endovascular interventions, either coronary or peripheral, should prevail over
classic surgery because of increased anesthetic and surgical complications in
this group. Difficult arterial access could be managed by using radial artery
or facilitated by ultrasound. 
Obese pts undergoing coronary angioplasty have similar 5-year outcomes with
normal weight counterparts, but they may have a higher rate of target vessel
revascularization and early stent thrombosis. Contrary, after peripheral
endovascular interventions underweight and normal BMI patients have lower
arterial patency, limb salvage and survival rates than obese patients. The
former group of pts has a more extensive form of peripheral artery disease at
the time of presentation. Obese pts that need endovascular aortic aneurysm
repair (EVAR) have extended operation times, but increasing BMI appears to
have minor impact on outcomes after EVAR. 
Further studies are needed to explain the obesity paradox in this patient
population.
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S08-6
ADIPOSE DERIVED STEM CELLS: FUTURE OPTIONS
Lina Badimon
Barcelona Cardiovascular Research Center, ICCC-CSIC, Hospital de la
Santa, Creu I Sant Pau, IIB-Sant Pau; Ciber OBENU, Instituto Carlos III
and Cátedra de Investigación Cardiovascular-UAB, Barcelona, Spain
lbadimon@csic-iccc.org 
Adipose tissue, traditionally regarded as an energy storage organ, is now
considered an endocrine tissue and a source of adult stem cells, adipose-
derived stem cells (ADSC). ADSC share many properties with the well-
described bone marrow-derived mesenchymal stem cells (BM-MSC)
including ex vivo expansion, differentiation capacity and mesenchymal
characteristic lineage markers. ADSC can be easily isolated from human
subcutaneous adipose tissue and in great quantities, what make them an
attractive alternative for cell therapy purposes. One of the most interesting
characteristic of ADSC is their potential to stimulate angiogenesis, reduce
apoptosis and exert anti-inflammatory properties suggesting an active role of
ADSC in revascularization of ischemic damaged tissues. Most of these effects
are believed to be mediated via paracrine activity.
At present, age, adipose tissue depot site, and gender have shown to modify
the number and the proliferation, differentiation and angiogenic capacity of
ADSC. However, the effect of cardiovascular risk factors on ADSC potential
has not been previously addressed. Indeed, several human studies have
demonstrated that hypercholesterolemia, diabetes, and hypertension impair
the number and function of bone marrow-derived circulating progenitor cells.
Yet, the effect of different degree of adiposity and/or metabolic syndrome on
the functional capability of adult stem cells, and particularly in ADSC is
presently investigated.
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S09A-1
ADAPTATION OF HEART FUNCTION IN CARDIAC
HyPERTROPHy DUE TO PRESSURE OVERLOAD
Naranjan S. Dhalla
Institute of Cardiovascular Sciences, St. Boniface Hospital Research,
Department of Physiology, Faculty of Medicine, University of Manitoba,
Winnipeg, Canada
NSDhalla@sbrc.ca 
Although cardiac hypertrophy is considered to be an adaptive mechanism for
the maintenance of heart function, myocardial subcellular alterations occurring
at different stages of its development are poorly understood.  By employing a
rat model of cardiac hypertrophy due to pressure overload, we have examined
functional, subcellular and biochemical changes after banding the abdominal
aorta at 4 and 8 weeks. The degree of cardiac hypertrophy, as evident from
increases in left ventricle (LV) wt and heart wt/body wt ratio, was associated
with activation of sympathetic nervous system, as seen from increases in
plasma catecholamine levels, at 4 and 8 weeks. Likewise, the activation of
renin-angiotensin system, as seen from increases in plasma angiotensin II and
angiotensin II converting enzyme levels, was also evident at 4 weeks and 8
weeks.  However, LV function was maintained at 4 weeks but was depressed
at 8 weeks of inducing pressure overload.  The activities of LV sarcolemmal
Na+-Ca2+ exchanger as well as sarcoplasmic reticular Ca2+-pump and Ca2+-
release channels were increased at 4 weeks but were depressed at 8 weeks of
cardiac hypertrophy. The observed alterations in Ca2+-transport systems in
hypertrophied LV and cardiac function at 8 weeks of pressure overload were
prevented by treatment of animals with β-adrenoceptor blockers or angiotensin
II receptor antagonists. These observations suggest that the status of
subcellular Ca2+-handling systems play a critical role in maintaining heart
function during the development of cardiac hypertrophy. (Supported by the
Canadian Institutes of Health Research)
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S09A-2
DIAgNOSIS OF MyOCARDIAL FIBROSIS
Alan G. Fraser
Wales Heart Research Institute, Cardiff University, UK
fraserag@cf.ac.uk 
Interstitial deposition of collagen in the heart is a key step in the progression
from chronically increased loading, to diastolic and systolic heart failure.
Direct methods of quantifying myocardial interstitial fibrosis by biopsy with
quantitative morphometry, which has shown substantial regional variations
within the left ventricle, or by biochemical analyses, are not relevant to routine
clinical practice. Serum markers of collagen metabolism that correlate with
myocardial fibrosis and which have been demonstrated to have diagnostic or
prognostic value include the C-terminal propeptide of type I procollagen (PIP),
the amino-terminal peptide of type III procollagen (PIIINP), several matrix
metalloproteinases (MMP-1, MMP-2, and MMP-9), and tissue inhibitor of
MMP levels. Many functional surrogate markers have been validated against
biopsies or serum assays, and they can be used to diagnose subclinical and
clinical disease and to monitor changes during treatment. Echocardiographic
measurements include the velocities and deformation of longitudinal function
of the left ventricle, particularly in the septum and both in systole and diastole.
Late gadolinium enhancement of magnetic resonance images is a non-specific
marker of expansion of the extracellular matrix with increased water content.
It is observed in diseases that cause myocardial oedema or replacement fibrosis
(scar) such as non-ST segment elevation myocardial infarction, and focal
abnormalities related to inflammatory disease such as cardiac sarcoidosis.
Diffuse interstitial fibrosis is more difficult to diagnose but it causes an
increase in the myocardial extravascular extracellular volume fraction and
correlates with a shorter global contrast-enhanced myocardial T(1) time. The
test now for the different non-invasive markers is to identify those which
should be integrated in the monitoring and therapeutic management of patients
because their use demonstrates an impact on the selection of treatment or on
clinical outcomes. 
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S09A-3
SUBCLINICAL LV DySFUNCTION AND PATHOLOgy
Franco Cecchi
Università di Firenze, Florence, Italy
francocecchi337@gmail.com 
Subclinical right or left ventricular dysfunction goes often undiagnosed, due
to mild or absent symptoms. It usually occurs in the early stage of
Cardiomyopathy, or as a result if ischemic, hypertensive or valvular disease.
Its recognition is crucial as appropriate management may slow disease
progression and even induce reverse remodelling.  
Cardiomyopathies (CM) comprise a group of myocardial diseases, whose
overall prevalence is estimated to be at least 3 ‰ in the general population.
Their recognition is increasing due to imaging techniques and greater
awareness in medical community.  They are often familiar inherited diseases,
usually with an autosomic dominant, more rarely recessive or x-linked
transmission. A variety of gene abnormalities are considered the cause of CM,
as they are responsible for Cardiomyocite dysfunction and death. The need of
a close cooperation among clinicians, geneticists and molecular biologists,
physiologists, in addition to imaging experts, pathologists, neurologists,
nephrologists and paediatricians is clearly established. CM are a good model
of  integration between basic and clinical sciences. A multidisciplinary
approach is necessary in order to ensure their correct diagnosis and
management. The recently revised (2008) Classification of Cardiomyopathies
by the European Society of Cardiology WG of myocardial and pericardial
diseases  seems to be particularly useful in daily clinical practice.
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S09A-4
CARDIAC RESTORATION By TISSUE ENgINEERINg
Richard Weisel
Cardiac Surgery at the University of Toronto, Regenerative Medicine at the
Toronto General Research Institute, Toronto, Canada
weisel9377@rogers.com 
Following an extensive myocardial infarction, the ventricular frequently thins
and dilates resulting in progressive heart failure despite intensive medical
therapy. Tissue engineering provides innovative alternative strategies to
stabilize the infarcted myocardium and prevent dilatation. Stem cell therapy
prevents  matrix remodeling by paracrine effects, but cell survival and
engraftment is very limited. Biodegradable, porous scaffolds seeded with cells
and cytokines increases cell survival and prevents remodeling. 
Surgical Ventricular Restoration (SVR) removes the infarcted region and
remodels the infarcted ventricle with a patch. The procedure converts a dilated
spherical ventricle to a more normal conical shape; it converts a European
soccer ball to an American football. The stiff, synthetic patch usually used for
SVR renders the remodeled regions scarred and non-elastic. The Surgical
Treatment for Ischemic Heart Failure (STICH) trial demonstrated that SVR
significantly reduced ventricular volumes but did not improve symptoms,
exercise ability, or global ventricular function. Modification of the patch
employed for SVR may improve the results obtained. We developed a new
biodegradable scaffold seeded with cells and cytokines which enhanced
cardiac healing, prevented recurrent dilatation and rejuvenated dysfunctional
cardiac resident stem cells. 
New biomaterials offer the promise the Tissue Engineering will restore
ventricular function after an extensive myocardial infarction. 
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S09B-1
ADAPTATION OF THE CARDIAC FUNCTION IN ATHLETES
Dragoş Vinereanu
Department of Cardiology,
“Carol Davila“ University of Medicine and Pharmacy, Bucharest, Romania
vinereanu@gmail.com
“Cardiac hypertrophy” refers to the remodeling of the cardiomyocytes and
adaptation of the cardiac function. This process may be due to cardiac
pathology or to exercise training. Exercise training is associated with
physiological cardiac adaptation, in order to response to the specific
hemodynamic requirements, which are different according to the age, gender,
and type of sport; therefore, two morphological forms of athlete’s heart can
be distinguished, an endurance-trained heart and a strength-trained heart.
Overall, “athlete’s heart” is characterized by preserved myocardial structure,
with a normal pattern of collagen metabolism and ventricular filling pressure,
and it is associated with “supranormal” cardiac function, with better diastolic
and systolic performance. Although it has been considered that “athlete’s
heart” is partly caused by increase in mechanical load, certain mechanisms,
that allow the heart to enlarge while maintaining a “supranormal function”,
are not known. Such mechanisms might be related to better ventriculo-arterial
coupling, with an improved endothelial and arterial function, related to lower
oxydative stress. This lecture will focus on the description of these
mechanisms, echo appearance of the athlete’s heart, and also on differentiation
from pathological hypertrophy, since this represents a serious condition that
may be associated with development of coronary heart disease, heart failure,
or sudden cardiac death.
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S09B-2
INVESTIgATINg INHERITED CARDIAC ARRHyTHMIAS By
MEANS OF INDUCED PLURIPOTENT STEM CELL-DERIVED
CARDIOMyOCyTES
Ofer Binah
Department of Physiology, Ruth & Bruce Rappaport Faculty of Medicine,
Technion, Israel Institute of Technology, Tel Aviv, Israel
binah@tx.technion.ac.il 
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) and Long–
QT Syndrome (LQTS) are inherited arrhythmias occurring in the absence of
structural heart diseases. Despite the paramount advancement in understanding
the diverse aspects of CPVT and LQTS, these fatal diseases still present high
mortality rates. While it is agreed that the clinical outcome of inherited
arrhythmias may be ameliorated by further basic research, accomplishing this
goal was hampered by the inability to obtain direct access to the affected
(diseased) myocytes, and thus investigate the actual functional derangements
resulting from the mutated gene. However, obtaining CPVT and LQTS-
specific cardiomyocytes has now become a viable option due to the
breakthrough inventions of Yamanaka and co-workers – the generation of
human induced pluripotent stem cells (iPSCs). Hence, to decipher in the actual
mutated myocytes, the functional changes and the underlying molecular
mechanisms of CPVT and LQTS (and other inherited cardiac pathologies),
researches are investigating mutated cardiomyocytes differentiated from iPSCs
derived from sick individuals. It is anticipated that this technology will provide
us the means to profoundly advance our understanding of CPVT and LQTS,
and hopefully to improve their future clinical outcome.
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S09B-3
DISTINCT EFFECTS OF VARIOUS ADAPTATION REgIMENS ON
ISCHEMIC TOLERANCE OF CHRONICALLy HyPOxIC HEARTS
Frantisek Kolar1, 
Neckar J.1, Borchert G.H.1, Hlouskova P.2, Micova P.2, Novakova O.2,
Novak F.2, Hroch M.3, Papousek F.1, Ostadal B.1
1Institute of Physiology, Academy of Sciences of the Czech Republic,
2Faculty of Science, Charles University in Prague, and 3Faculty of Medicine
in Hradec Králové,  Charles University in Prague, Czech Republic
kolar@biomed.cas.cz 
The aim was to find out whether brief reoxygenations during adaptation to
chronic continuous hypoxia (CCH) affect cardioprotection. Adult male rats
were kept at CCH (FIO2=0.1) for 5−30 days; a subgroup of animals was
exposed to room air daily for a single 60-min period. While 5-day CCH did
not affect myocardial infarction induced by regional ischemia/reperfusion, 15
and 30 days reduced infarct size from 62% of area at risk in controls to 52%
and 41%, respectively. Susceptibility to ischemic arrhythmias exhibited
reciprocal development. CCH up-regulated myocardial antioxidant defense
systems without affecting malondialdehyde. Reoxygenation abolished both
the infarct size-limiting effect of CCH and upregulation of antioxidants,
resulting in oxidative stress. Cardiomyocytes from CCH rats exhibited better
resistance to injury than cells from normoxic and reoxygenated groups. The
cytoprotective effect of CCH was attenuated by the large-conductance Ca2+-
activated K+ (BKCa) channel blocker paxilline, whereas the opener NS1619
reduced injury in the normoxic group but not in the CCH group.
Reoxygenation restored the NS1619-induced protection, whereas paxilline
had no effect, resembling the normoxic group pattern. Results suggest that
CCH is cardioprotective and brief daily reoxygenation blunts its salutary
effects, likely by interfering with the activation of mitochondrial BKCa
channels and suppressing antioxidant defense.
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S09B-4
TRANSCRIPTIONAL CONTROL OF DILATED
CARDIOMyOPATHy IN THE ABSENCE OF HyPERTROPHy
Balwant S. Tuana 
Department of Cellular and Molecular Medicine, University of Ottawa
Heart Institute, Ottawa, Ontario, Canada 
btuana@uottawa.ca 
The E2F/Rb pathway is comprised of a dozen distinct proteins which are
expressed in a cell/tissue specific context to regulate genes involved in
proliferation, differentiation, and death. Perturbation of the E2F/Rb pathway
through modulation of its members induces changes in the cell cycle which
could potentially be targeted in cell growth and death. However, the
constellation of E2Fs and Rb family members and their exact role in cardiac
growth and development remains to be fully examined.  In order to modulate
the E2F pathway in vivo in mouse myocardium, we expressed E2F6 (a
transcriptional repressor of E2F responsive genes) under the control of the alpha
myosin heavy chain promoter. The transgenic (tg) mice exhibited dilated
cardiomyopathy (DCM) and microarray, microRNA array and protein
expression profiling was utilized to identify targets which were sensitive to
E2F6 levels. E2F responsive transcripts involved in cell cycle regulation
including E2F1 and E2F3 were up regulated in Tg hearts, but did not induce
changes in cardiomyocyte size or number. Western blot analysis indicated that
several proteins were down-regulated post-transcriptionally, and microRNA
array detected the induction of non-cardiac microRNAs which were linked to
a post-transcriptional loss of the gap junction protein connexin-43. A specific
activation of the Extracellular receptor kinases (ERK) which has been linked
to transcriptional control and DCM was also apparent in E2F6 Tg mice. Thus
precise transcriptional control via the E2F/Rb pathway of cardiac gene
expression is critical for normal cardiac growth and function. Funded by CIHR. 
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S09C-1
LTBP-2 IS A NOVEL BIOMARKER IN HEART FAILURE - 
A PRELIMINARy STUDy
Yingjie Wei
State Key Laboratory of Cardiovascular Disease, 
National Center for Cardiovascular Disease & Fuwai Hospital, 
Chinese Academy of Medical Sciences
Peking Union Medical College, Beijing, China
weiyingjie@fuwaihospital.org
We have observed increased expression of latent TGF-β binding protein
(LTBP)-2 mRNA in human failing hearts. This study was aimed to further
confirm that LTBP-2 acts as a novel marker in human acute heart failure.
We demonstrated that median level of LTBP-2 in myocardial samples from
heart failure patients was significantly elevated, and TGF-β1 significantly
promoted LTBP-2 expression in neonatal rat cardiomyocytes. To investigate
the potential of LTBP-2 as a biomarker to diagnose heart failure with reduced
ejection fraction (HFREF), another cohort of 133 consecutive patients with
dyspnea were enrolled. In receiver operating characteristic (ROC) curve
analyses to detect HFREF, LTBP-2 achieved an area under curve (AUC) of
0.67 (95% confidence intervals (CI) 0.58–0.75), comparable to the diagnostic
ability of NT-proBNP (AUC =0.68, 95% CI 0.59–0.77). 
The serum LTBP-2 levels might act as a promising biomarker in HFREF.
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S09C-2
ADAPTIVE AND MAL-ADAPTIVE SIgNALINg IN CELLS OF THE
CARDIOVASCULAR SySTEM: 
IT’S NOT HOW MUCH BUT WHERE
Donald H. Maurice
Department of Biomedical and Molecular Sciences,
Cardiac, Circulatory and Respiratory Program,
Queen’s University, Kingston, Ontario, Canada
mauriced@queensu.ca 
Non-communicable, chronic diseases, including, a) heart diseases, such as
atherosclerosis and hypertension, b) stroke, c) cancer and d) diabetes are
responsible for ~60% of all deaths in developing and developed countries.
Heart diseases and stroke remain leading causes of death and disability. Cancer
continues to claim more lives each year and rivals cardiovascular illness as
Canada’s leading cause of death. Nearly 7% of Canadians are diabetic and an
increasing percentage is insulin resistant, placing them at risk of diabetes.
Currently, these diseases account for ~75% of health care spending in Canada.
Although a majority of Canadians express the opinion that health care systems
should emphasize prevention strategies, and state supporting funding of
prevention programs, the reality is that participation rates in prevention
programs are low. Indeed, in North America, 1 in 3 adults are obese. Most
disturbingly, 1 in 5 girls and boys between the ages of 6 and 19 is obese and
has two or more risk factors for heart disease, including high blood pressure,
high cholesterol, diabetes, current smoking and physical inactivity. Research
has unequivocally linked obesity, the metabolic syndrome, ‘a clustering of
atherosclerotic cardiovascular disease risk factors characterized by visceral
adiposity, insulin-resistance, low HDL cholesterol, and a systemic pro-
inflammatory state’ and other components of “modern life”, such as physical
inactivity, as factors that increase the burden of chronic disease. Our studies
have elucidated some of the mechanisms through which the endothelium
integrates these myriad physio-pathological stimuli and takes advantage of the
findings to highlight novel potential therapies to promote adaptive endothelial
functions and to reduce the chronic disease-associated mal-adaptive actions
of the endothelium.
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S09C-3
CARDIAC MICRO-RNAs IN 
HUMAN END-STAgE HEART FAILURE
Jan Kyselovic
Doka G., Krenek P., Mlynarova J., Gonçalvesova E., Hulman M., 
Klimas J., Peter Musil
Comenius University, Faculty of Pharmacy, 
Department of Pharmacology and Toxicology,
The National Institute of Cardiovascular Diseases
Bratislava, Slovak Republic
kyselovic@fpharm.uniba.sk
Heart failure syndrome is a serious health issue that affects 2-3% of population.
Identification of responsible regulatory mechanisms which may contribute to
development or progression of the disease is highly challenging with respect
to developments of novel therapeutic strategies. Myosin is the molecular motor
of contraction. In the heart, three distinct myosin heavy chain isoforms coexist
in delicate balance. As has been recently shown, the shift from one myosin
isoform to other may be one of key factors causing heart failure. In this study
we aimed to analyze gene expression of myosin heavy chain isoforms in
failing hearts.
We examined samples from left ventricles of 30 patients with end-stage heart
failure indicated for heart transplantation. We used quantitative RT-PCR to
measure mRNA levels of cardiac myosin heavy chain isoforms (MYH6,
MYH7, MYH7B), related transcription factors (GATA4, SRF, NKX-2.5, YY1)
and microRNAs (miR-1, -133a, -208a, -208b, -499, -29b), based on
bioinformatic predictions and databases.
In adult human failing hearts, we found the slow-twitch myosin heavy chain
MYH7 (~98%) to be the predominantly expressed isoform whereas fast-twitch
MYH6 isoform constitutes just about 1% of all myosin isoforms. This
excessive expression of MYH7 is regulated by several transcription factors
and microRNA, which expression is also altered. Conclusively, dysregulated
gene expression of myosin heavy chains resulting in MYH7 upregulation and
MYH6 downregulation might be an adaptation in heart failure and interesting
target for future pharmacotherapy.
Support: VEGA 1/0109/08, VEGA 1/0357/09, VEGA 1/0786/11
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S09C-4
THE USE OF A NOVEL DIETARy SUPPLEMENT TO REgULATE
BLOOD PRESSURE: POWERFUL RESULTS FROM A
RANDOMIzED TRIAL
Grant N. Pierce1,3*, Delfin Rodriguez-Leyva1,3, Randy Guzman2,4*
*Co-Principal Investigators
1Institute of Cardiovascular Sciences, St Boniface Hospital Research Centre,
2Asper Clinical Research Institute, St Boniface Hospital, 
Departments of 3Physiology, 4Surgery, University of Manitoba, 
Winnipeg, Canada
GPierce@sbrc.ca 
Flaxseed is an important source of omega-3 fatty acids, antioxidants and fibre.
The primary objective of this study was to determine whether consumption of
a diet rich in milled flaxseed over six months has any beneficial effects on
blood pressure (BP) regulation in patients with peripheral arterial disease
(PAD). This is a single centre, placebo-controlled, double-blinded, randomized
trial in 110 patients with PAD. Patients received 30 g of milled flaxseed (or
placebo)/day. Resting brachial systolic and diastolic pressures were measured.
All trial participants were diagnosed with PAD and on anti-hypertensive
medication. Baseline systolic and diastolic BP was 143 and 78 mm Hg,
respectively. After 6 months of flaxseed treatment, systolic and diastolic BP
was 10 mm and 7 mm Hg lower, respectively, than the placebo group (P<
0.05). The dosage of anti-hypertensive medication was unchanged by flax.
The anti-hypertensive effects of dietary flaxseed were exhibited most by
patients who entered the study with systolic BP of >140 mm Hg. We conclude
that dietary flaxseed can decrease BP in PAD patients even on anti-
hypertensive medication. These decreases in BP would be expected to reduce
strokes and myocardial infarctions by at least 30-46%. 
Supported by Flax2015, the Agri-food Research and Development Initiative,
Canada Bread, CIHR and St Boniface Hospital Foundation.
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S-10 Symposium
“Myocardial ischemia and reperfusion”
Chaired by: A. Tosaki, J. Slezak
Date: Sunday, June 10th
Starting time: 08:30 
Location: Main Hall (Ronda)
1. R.C. Kukreja
Role of microRNA in Cardioprotection
2. A. Tosaki
The role of heme oxygenase-1 in myocardial ischemia
and reperfusion
3. F. Boucher
Evolution of cytokine expression and insulin sensitivity in
the myocardium after preperfused infarction in rats
4. D.J. Hausenloy
Remote ischemic conditioning: Bench to bedside and
back again
5. Tanya Ravingerova
Lifestyle-related risk factors of cardiovascular diseases
alter myocardial response to ischemia via interference
with cellular adaptive mechanisms
6. J. Slezak
Chronic myocardial ischemia and mediastinal
irradiation injury
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S10-1
ROLE OF MICRORNA IN CARDIOPROTECTION
Rakesh C. Kukreja
Pauley Heart Center, Division of Cardiology, Virginia Commonwealth
University, Richmond, Virginia, USA
rakesh@vcu.edu
MicroRNAs (miRNAs) have emerged as a novel class of endogenous, small,
non-coding RNAs that negatively regulate gene expression via degradation or
translational inhibition of their target mRNAs. In the heart, miRNAs have been
involved in several clinical scenarios including ischemia/reperfusion and
preconditioning suggesting that regulation of their function could be used as
a novel cardioprotective strategy.  In particular, miRNA-1, miRNA-21,
miRNA-24, miRNA-29, miRNA-92a, miRNA-126, miRNA-133, miRNA-
320, miRNA-199a, miRNA-208 and miRNA-195 have been shown to be
regulated after myocardial infarction. Following ischemic preconditioning
(IPC), we observed significant increase in miRNA-1, miRNA-21and miRNA-
24 in the heart. Treatment with the miRNAs derived from the hearts subjected
to IPC protected the hearts against ischemia/reperfusion injury, as shown by
a reduction of infarct size as compared with saline or non-IPC miRNA-treated
control. This protective effect was abolished by treatment with the miRNA-
21 inhibitor. In addition, one of the powerful pharmacological preconditioning
agent, sildenafil (Viagra) resulted in upregulation of miRNA-21 in the heart.
Pretreatment of hearts with adenoviral vector encoding miR-21eraser prior to
sildenafil preconditioning abolished the infarct limiting effect of sildenafil.
These results suggest that miRNA-21 is one of important mediator of
cardioprotection induced by IPC and sildenafil. 
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S10-2
CARBON MONOxIDE SIgNALLINg IN BIOLOgICAL
PROCESSES MEDIATED By HEMEOxygENASE-1
Arpad Tosaki
Department of Pharmacology, School of Medicine, Faculty of Pharmacy,
University of Debrecen, Debrecen, Hungary
tosaki.arpad@pharm.unideb.hu 
Cutting edge of biotechnology holds the potential for characterization of events
which follow and contribute to pathologically altered physiological functions.
Rapidly expanding understanding of basic disease mechanisms will translate
into greatly improved healthcare strategies. Heme oxygenase-1 (HO-1)-related
mechanisms are a major homeostatic countermeasure by which vertebrate
biological systems manage many disease states including myocardial and renal
ischemia/reperfusion, hypertension, cardiomyopathy, organ transplantation,
endotoxemia, lung diseases, and immunosuppression. In the past decades,
significant progress has been made in understanding of the function and
regulation of HO-1. Here a summary is presented of current understanding of
the role of the HO-1 related endogenous carbon monoxide (CO) production
in various diseases, focusing on myocardial ischemia/reperfusion-induced
injury. Various factors are considered which influence the HO-1 system in the
context of endogenous CO production. An assessment will also be made as to
how this evolving understanding may contribute to pharmacological
approaches to therapeutic use of HO-1 manipulation. Upregulation of HO-1
is a widely distributed adaptive response to a wide variety of influences,
especially oxidative insults. Thus, strategies for use of HO-1 as definitive
prophylaxis or treatment for inflammatory pathologies are expected to
increasingly make use of pharmacological agents capable of increasing activity
of the enzyme.
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S10-3
EVOLUTION OF CyTOKINE ExPRESSION AND INSULIN
SENSITIVITy IN THE MyOCARDIUM AFTER PREPERFUSED
INFARCTION IN RATS
François Boucher 
TIMC-IMAG Laboratory, University Grenoble 1 – UJF, La Tronche, France
Francois.Boucher@ujf-grenoble.fr 
Pro-inflammatory mediators and chemokines have been shown to play a role
in the pathophysiology of heart failure. We have investigated whether such a
phenomenon also occurs after short-term myocardial ischemia in-vivo rats.
Temporary ischemia induced a progressive cardiac dysfunction and left
ventricular (LV) remodelling, characterized by LV free wall thinning and
cavity dilation. Besides, a transient and marked increase in TNF-α, IL1ß, IL6,
LIX, CINC2, CINC3, MIP3-α and leptin production was also observed in the
myocardium 8 days after surgery. Leptin inhibition, by intra-cardiac antisens
therapy prevented the development of adverse remodelling and reduced
cytokine production. Finally, cardiac insulin sensitivity, assessed by nuclear
imaging using a new tracer of glucose uptake, was shown to be transiently
reduced concomitantly with leptin overproduction.
These findings support the hypothesis that early events after myocardial
infarction, involving leptin-induced metabolic perturbations and cytokine
overproduction, may play a role in the adaptive process and remodelling of
the myocardium. We suggest that these events might be some of the triggers
of the adverse cardiac phenotype that leads to heart failure.
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S10-4
REMOTE ISCHEMIC CONDITIONINg: 
BENCH TO BEDSIDE AND BACK AgAIN
Derek J. Hausenloy
British Heart Foundation, The Hatter Cardiovascular Institute,
University College London, UK
d.hausenloy@ucl.ac.uk
Cardiovascular disease is the leading cause of death and disability worldwide.
Remote ischemic conditioning (RIC) represents a therapeutic strategy for
harnessing the body’s endogenous protective capabilities against the injury
incurred by episode of acute lethal ischemia and reperfusion. It describes the
intriguing phenomenon in which transient non-lethal ischemia and reperfusion
of one organ or tissue confers resistance in a remote organ or tissue to a
subsequent episode of acute lethal ischemia reperfusion injury. In its original
conception in the experimental setting, it described intramyocardial protection
which could be relayed between two different coronary artery territories. It
soon became apparent from animal studies that myocardial infarct size could
be dramatically reduced by applying cycles of brief ischemia and reperfusion
to an organ or tissue remote from the heart before the onset of myocardial
infarction. The concept of remote organ protection has now been extended
beyond that of solely protecting the heart to providing a general form of inter-
organ protection against ischemia-reperfusion injury. The concept of RIC has
been successfully applied in the clinical setting to protect the heart during
coronary artery bypass graft surgery, percutaneous coronary intervention and
during an acute myocardial infarction. However, the mechanism underlying
RIC remain unclear and have been attributed to a neuro-hormonal pathway
linking the organ or tissue in which the RIC stimulus is applied to the target
organ. Therefore, further basic science studies are now required to elucidate
the pathways involved in RIC protection. In my talk, I will provide an
overview of history and evolution of RIC, the potential mechanistic pathways
underlying its cardioprotective effect, and its emerging application in the
clinical setting.   
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S10-5
LIFESTyLE-RELATED RISK FACTORS OF CARDIOVASCULAR
DISEASES ALTER MyOCARDIAL RESPONSE TO ISCHEMIA VIA
INTERFERENCE WITH CELLULAR ADAPTIVE MECHANISMS
Táňa Ravingerová1
Slávka Čarnická1, Martina Nemčeková1, Veronika Ledvényiová1, Adriana
Adameová2, Marek Zálešák1, Antigone Lazou3, František Kolář4
1 Institute for Heart Research, Slovak Academy of Sciences, 
Centre of Excellence SAS NOREG, 2 Department of Pharmacology and
Toxicology, Faculty of Pharmacy, Comenius University, Bratislava,
Slovakia; 3 School of Biology, Aristotle University of Thessaloniki,
Thessaloniki, Greece; 4 Institute of Physiology, Academy of Sciences of the
Czech Republic, Prague, Czech Republic
Tatiana.Ravingerova@savba.sk
Lifestyle-related risk factors (RF) of cardiovascular diseases, such as stress,
hypertension, and metabolic disorders have a negative impact on the heart exposed
to ischemia facilitating its lethal injury. On the other hand, some RF-related stimuli
including ischemia(hypoxia), high glucose and/or free radicals, may trigger
adaptive processes in the heart resulting in its greater resistance to
ischemia/reperfusion injury (IRI) known as preconditioning (PC), which is a
characteristic feature of the female and acutely diabetic myocardium (recently
termed as metabolic PC). We hypothesized that RF may modify cardiac response
to ischemia not only by interference with pathophysiological mechanisms of IRI
per se, but via suppression of the innate cardioprotection. While hearts of
hypertensive (SHR) rats and male counterparts of age-matched females were more
sensitive to IRI manifested by a larger extent of irreversible injury (infarction),
acute STZ-induced diabetes or fat-cholesterol diet alone did not alter cardiac
susceptibility to ischemia. However, combination of RF markedly exacerbated
IRI facilitating pro-oxidative and apoptotic processes. On the other hand, PC still
conferred an effective protection, although its extent was lower in SHR and older
animals. Research shows that protective effects of adaptation may be attenuated
in RF-affected heart, although potential of intrinsic cardioprotection is still retained
even in pathologically altered myocardium that requires a higher intensity of the
preconditioning stimulus. Cardioprotective pleiotropic (independent of the
primary) effects of PPAR agonists, hypolipidemic and antidiabetic drugs, indicate
a promising approach to reactivate myocardial ischemic tolerance in healthy and
diseased myocardium. Grants VEGA-SR 1/0638/12, 2/0054/11, 2/0101/12,
APVV-LPP-0393-09, APVV-0523-10, APVV-SK-CZ-0199-11.
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S10-6
CHRONIC MyOCARDIAL ISCHEMIA AND MEDIASTINAL
IRRADIATION INJURy
Jan Slezak 1
N. Tribulova 1, M. Ivanova 1, J. Styk 1, K. Frimmel 1, T. Ravingerova 1, 
M. Fulop 2, L. Okruhlicova 1
1 Institute for Heart Research, Slovak Academy of Sciences, 2 Slovak Medical
University, Bratislava, Slovak Republic
Jan.Slezak@savba.sk 
Chronic ischemic injury of the myocardium is increasingly recognized as an
undesired side effect of radiation of cardiovascular system after mediastinal
radiation therapy for malignancies.
The study concentrates on pathology of  radiation-induced  cardiovascular
toxicity and on prevention of injury of  healthy tissues in areas at risk.
Irradiation of the heart with a single dose of 20 Gy delivered to the heart region
was performed on male Wistar rats. 
Adverse effect of ionizing radiation is mostly mediated by reactive oxygen
and nitrogen species, which deplete antioxidant stores. Radiation damage of
cardiovascular system shows that endothelial cells are the most radiation
sensitive part of vasculature. Microvascular injury leads to myocardial
ischemia.  
Chronic myocardial underperfusion results in pathophysiological reaction
connected with protective mechanism. Myocytes adjust its contraction
function which is characterized by down regulation in energy utilization,
attenuated level of contractile function, upregulation of stress proteins,
cardiomyocyte dedifferentiation and by  myocyte remodeling. 
Morphologically, chronic hypoperfusion results in loss of myofilaments,
increased amount of glycogen and small dark mitochondria, typical signs of
hibernating myocardium.
Protection of normal tissue against radiation-induced damage may increase
the therapeutic benefit of radiotherapy. Different  more or less effective
measures to prevent radiation-induced injury and to increase cardiovascular
tolerance to irradiation of healthy tissue have been evaluated. Further
investigation is needed to determine the most effective  prevention of radiation
injury to healthy tissues accidentally targeted by radiation.  
Supported by VEGA Grant 2/0207/11.
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S-11-A Symposium
“Signaling mechanisms of adaptation to
hypoxia”
- I -
Chaired by: F. Downey, I.Y. Malyshev
Date: Friday, June 8th
Starting time: 12:00 
Location: Main Hall (Ronda)
1. P.S. Wang
Effects of Intermittent Hypoxia on the Production of
Testosterone in Rats
2. yulia I. Kirova
The role of oxidative stress in the induction of
transcription factors at different stages of adaptation to
hypoxia
3. I.y. Malyshev
Hypoxia-induced reprogramming of macrophages: Role
in tumorigenesis
89
S11A-1
EFFECTS OF INTERMITTENT HyPOxIA ON THE PRODUCTION
OF TESTOSTERONE IN RATS
Paulus S. Wang 1*
Yu-Min Cho2, Hsiao-Fung Pu2, Chiung-Feng Fang2, Shyi-Wu Wang 2*
1Department of Physiology, School of Medicine, National Yang-Ming
University, Taipei, and 2Department of Physiology and Pharmacology,
Chang Gung University, Taoyuan, Taiwan
pswang@ym.edu.tw
The hypoxia-stimulated response of endocrine systems depends on the variety and
duration of hypoxia. Our previous study reported that hypoxia induced the
testosterone release in rats. However, the mechanisms are unclear.
Male rats were divided into 2 groups. Chronic intermittent hypoxia (CIH) rats were
housed in a 12 % O2 hypoxic chamber, 8 h/d for 14 days. Normoxic rats were used
as control animals. Rats were catheterized and single injected with hCG (5 IU/ml/kg)
via right jugular vein. Blood samples (0.3 ml each) were collected at different time
intervals. Rat Leydig cells were purified and challenged with hCG (0.01 IU/ml),
forskolin (10-5 M), 8-bromo-cAMP (10-4 M), A23187 (10-5 M), cyclopiazonic acid
(CPA, 10-4 M), or androstenedione (10-8 M), and then the media were collected for
investigation of cAMP-, Ca2+-, and 17β-hydroxy steroid dehydrogenase(HSD)-
related testosterone production. The concentrations of testosterone were measured
by the radioimmunoassay. Furthermore, the Leydig cells were incubated with
trilostane (10-5 M) and/or 25-OH-hydroxycholesterol (25-OH-C, 10-5 M), and then
the media were collected for pregnenolone assay. The mRNA expression of LH
receptor in rat Leydig cells was analyzed by RT-PCR technique. The protein
expression of LH receptor in Leydig cells was detected by the Western blot method.
We showed that 14-d CIH enhanced the plasma testosterone levels but decreased
the serum LH levels. The plasma testosterone levels of CIH group were higher than
normoxic group at several time intervals subsequent to the injection. The evoked-
release of testosterone and pregnenolone of Leydig cells in vitro were significantly
increased in CIH group. Moreover, CIH significant increased the mRNA and
protein expressions of LH receptor and expression of P450scc in Leydig cells but
not the expression of steroidogenic acute regulatory protein (StAR). In addtion,
CIH increased the concentrations of peripheral and testicular serum vascular
endothelial growth factor (VEGF). The vessel distribution on testes in CIH rats was
more and also more obvious than in normoxic rats.These results su ggested that
14-d CIH induced the functional capacity to secrete testosterone might be partially
through the mechanisms involving the induction of LH receptor expression,
P450scc activity, cAMP pathway, 17β-HSD activity, and calcium-related pathway
in rat Leydig cells. CIH significant increased the testicular angiogenesis.
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S11A-2
THE ROLE OF OxIDATIVE STRESS IN THE INDUCTION OF
TRANSCRIPTION FACTORS AT DIFFERENT STAgES OF
ADAPTATION TO HyPOxIA
Yulia I. Kirova
Department Molecular and Cellular Pathophysiology
Lab. of Bioenergetics, Institute of General Pathology and Pathophysiology,
Russian Academy of Medical Sciences, Moscow, Russia
bioenerg@mail.ru
Hypoxic preconditioning induces two-phase increase of HIF-1α expression in
the neocortex of low-resistance rats. The first, brief phase appears after each
hypoxic episode and rapidly disappears in normoxic conditions. The second
increase of HIF-1α expression occurs in 24 hours after the hypoxic episode.
The phase-nature of HIF-1α expression corresponds to the dynamics of urgent
and long-term resistance in low-resistance rats, which suggests the HIF-1α
involvement in mechanisms of urgent and long-term adaptation. Hypobaric
hypoxia or interval normobaric hypoxia in the preconditioning regimen did
not significantly influence free-radical production and lipid peroxidation or
even suppressed this process within the first day of exposure. Therefore,
formation of urgent adaptation to hypoxia can occur in the absence of oxidative
stress. In high-resistance rats, hypoxia preconditioning does not influence the
HIF-1α protein expression and the adaptation. Severe hypoxia inhibits the
HIF-1α protein expression in the neocortex of both rat phenotypes, depresses
the formation of urgent resistance, abolishes the induction of long-term
adaptation, initiates oxidative stress with increased free-radical production and
lipid peroxidation. Therefore, (1) formation of urgent adaptation to hypoxia
can occur in the absence of oxidative stress and (2) free-radical processes are
not unique trigger mechanism that initiates transcriptional and adaptogenic
HIF-1α functions.
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S11A-3
HyPOxIA-INDUCED REPROgRAMMINg OF MACROPHAgES:
ROLE IN TUMORIgENESIS
Igor Yu Malyshev1,2
Kruglov S.V. 1,2, Kalish S.V.1
1Moscow State University of Medicine and Dentistry, Moscow, Russia
2Institute of general Pathology and Pathophysiology, Moscow, Russia
igor.malyshev@mtu-net.ru
Pathogenetic effects of hypoxia may be related with influences on immune
responses. Accumulation of macrophages in hypoxia areas is the key point in
understanding the mechanisms of hypoxia effects on immunity. We have
investigated the effect of hypoxia on the macrophage phenotype and
phenotypic plasticity and to determine the resistance to acute hypoxia in
C57/BL mice, which have the pro-inflammatory M1 macrophage phenotype,
and in BALB/c mice, which have the anti-inflammatory M2 macrophage
phenotype. The following results were obtained. 1) The response of
macrophages to acute hypoxia has two successive phases, the immediate, anti-
inflammatory phase, and the delayed, pro-inflammatory phase. This response
was more distinctly inverted in С57/BL6 M1 macrophages than in ВАLB/c
M2 macrophages; 2) the effect of acute hypoxia on macrophage phenotypic
plasticity depends on the genetically predetermined, original macrophage
phenotype. In this process, a clear regularity was observed: hypoxia increased
the capability of macrophages for changing into the pro-inflammatory M1
phenotype, while their capability for changing into the anti-inflammatory M2
phenotype remained virtually unaffected. 3) BALB/c mice were more resistant
to acute hypoxia than C57/BL6 mice. Taken together, these data expand our
understanding of mechanisms for pathogenetic and protective effects of
hypoxia in inflammation and tumorogenesis.
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S-11-B Symposium
“Signaling mechanisms of adaptation to
hypoxia”
- II -
Chaired by: P.S. Wang, G. Melillo
Date: Friday, June 8th
Starting time: 14:30 
Location: Main Hall (Ronda)
1. Tatiana Serebrovskaya
Migration pathways of hematopoietic stem cells in the
mechanisms of adaptation to acute and intermittent
hypoxia
2. Benedetta Bussolati
The plasticity of human renal CD133+ progenitors is
modulated by hypoxia through Oct4/miR-145 balance
3. F. Downey
Anti-hypertensive effects of adaptation to hypoxia
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S11B-1
MIgRATION PATHWAyS OF HEMATOPOIETIC STEM CELLS
(HCS) IN THE MECHANISMS OF ADAPTATION TO ACUTE AND
INTERMITTENT HyPOxIA
Tatiana V. Serebrovskaya1
Nikolsky I.S.2, Ishchuk V.A.3
1Bogomoletz Institute of Physiology, Kiev, Ukraine
2Institute of Genetic and Regenerative Medicine, Kiev, Ukraine
3State Institute of Gerontology, Kiev, Ukraine
sereb@biph.kiev.ua
HSCs play an important role in the homeostasis and turnover of peripheral
tissues. Experiments on animals testify that exposure to intermittent hypoxia
(IH) promotes induction of distinct HSC chemoattractant gradients and
mobilizes HSC from bone marrow to peripheral circulation. This process is
regulated by chemokines and cytokines. Present study was designed to
compare the effects of intermittent versus acute hypoxia on human HSCs and
some immune parameters.  A two-week IH program (5 min exposures to 10%
O2 with intervening 5 min room air breathing, 4 times a day) caused a decrease
in circulating HSCs 1 wk after IH, lowered TNF-α and IL-4 and sharply
increased IFN-γ, augmented phagocytic and bactericidal activities of
neutrophils, activated complement and some immunoglobulins. In contrast to
2-wk IH program, single IH session increased HSC during hypoxic cycles;
this effect subsided within 30 min after hypoxic session. Results raise the
possibility that IH induces HSC emigration from niches into the circulation,
followed by homing and sequestration in target tissues during post-hypoxic
recovery. The IH-induced decrease in blood TNF-α content with simultaneous
increase in IFN-γ could contribute to the moderation of infectious-
inflammatory processes. Further studies are required to elucidate the fate of
IH-activated HSCs in circulating blood and investigate their role within
specific tissue compartments.
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S11B-2
THE PLASTICITy OF HUMAN RENAL CD133+ PROgENITORS IS
MODULATED By HyPOxIA THROUgH OCT4/MIR-145
BALANCE
Aldo Moggio, Giovanni Camussi, Benedetta Bussolati
Molecular Biotechnology Centre, University of Torino, Italy
benedetta.bussolati@unito.it 
The tubular compartment of the nephron displays a high regenerative ability.
We previously isolated CD133+ stem/progenitor cells in the tubular
compartment of the human kidney. However, their possible contribution to
repair is unknown. We here evaluated the possible modulation of CD133+ cells
by the hypoxic environment, the molecular mechanisms involved and their
possible involvement in renal regeneration. 
CD133+ progenitors cultured under hypoxia (1%O2) showed increased
proliferation and clonogenic ability. When injected in vivo, CD133+ hypoxic
progenitors showed ability to differentiate in structures resembling the
different segments of the nephron. Moreover, hypoxia up-regulated Oct-4
isoforms in CD133+ cells via regulation of  the Oct4 promoter. In parallel,
hypoxia downregulated microRNA-145, known to act as an Oct4
transcriptional repressor. Epithelial differentiation increased microRNA-145
and reduced Oct4 level, suggesting a balance between Oct4 and microRNA-
145. MicroRNA-145 over-expression in CD133+ cells induced down-relation
of Oct4 at the protein level, inhibited cell proliferation and stimulated
differentiation. Labelled CD133+ progenitors localized into the injured kidneys
in a model of acute renal damage and promoted renal functional regeneration.
These results suggest that hypoxia may direct CD133+ progenitors toward a
more stem phenotype via Oct4A/miR145 balance. The plasticity of renal
CD133+ cells could be exploited in renal regeneration after hypoxic damage.
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S11B-3
ANTIHyPERTENSIVE EFFECTS OF ADAPTATION TO HyPOxIA
Fred H. Downey1, Eugenia B. Manukhina1,2
1Univ. N. Tex. Hlth. Sci. Ctr., Fort Worth, TX 76107 USA;
2Inst. Gen. Pathol. and Pathophysiol., Moscow, Russia
Fred.Downey@unthsc.edu 
Adaptation to hypoxia and its effect on blood pressure (BP) has been
investigated under many circumstances, in various models, and with varying
protocols. Thus, it is not surprising that there is no consensus regarding this
clinically relevant topic. BP of people living at high altitude differs little from
that of lowlanders, but hypertension is less evident. However, life style and
diet are confounding factors.  The rise of BP of spontaneously hypertensive
rats is blunted by continuous hypoxia and by some protocols of intermittent
hypoxia.  Hypertensive patients have been treated successfully by adaptation
to hypoxia, yet the intermittent hypoxia of sleep apnea causes hypertension.
Whether or not adaptation to hypoxia is antihypertensive depends on the
balance of vasoconstrictory and vasodilatory mechanisms activated by
different hypoxic regimens. Antihypertensive mechanisms include increased
vascularity, NO production and storage, reduced vascular Ca++, and improved
salt and water metabolism; as well as, blunting of vasoconstrictory
mechanisms, including sympathetic activation and angiotensin. Hypertensive
responses to stress may also be blunted, with resulting reduction in BP.
Clearly, more research is required to understand the effects of hypoxia on BP,
especially if adaptation to hypoxia is to be used clinically as a complementary
or alternative therapy for hypertension.
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S-12 Symposium
“Cardiac stem cells”
Chaired by: P.A. Doevendans, M. Pesce
Date: Saturday, June 9th
Starting time: 08:30 
Location: Hall B (Salonul Oglinzilor)
1. V. Lionetti
Self-Renewing heart in the era of stem cells:  who have
saved the heart of Prometheus?
2. Elisa-A. Liehn
Cell therapy after myocardial infarction: present and
future
3. M. Pesce 
Cardiovascular stem cells: from regeneration to
engineering
4. P.A. Doevendans
Cardiac stem cells: the solution
5. Mihaela gherghiceanu 
Cardiac stem and progenitor cells by electron
microscopy/tomography
6. S.F. yet
Cytoprotection of heme oxygenase-1 in embryonic stem
cells and cardiovascular system
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S12-1
SELF-RENEWINg HEART IN THE ERA OF STEM CELLS: 
WHO HAVE SAVED THE HEART OF PROMETHEUS?
Vincenzo Lionetti
Laboratory of Medical Science, Institute of Life Sciences, Scuola Superiore
Sant’Anna, Pisa, Italy
v.lionetti@sssup.it 
A heart attack kills off many cells in the heart. Parts of the heart become thin
and fail to contract properly following the replacement of lost cells by scar
tissue. However, the notion that the same adult cardiomyocytes beat
throughout the lifespan of the organ and organism, without the need for a
minimum turnover, gives way to a fascinating investigations. Since the late
1800s, scientists and cardiologists wanted to demonstrate that the
cardiomyocytes cannot be generated after the perinatal period in human
beings. This curiosity has been passed down in subsequent years and has
motivated more and more accurate studies in an attempt to exclude the
presence of renewed cardiomyocytes in the tissue bordering the ischaemic
area, and then to confirm the dogma of the heart as terminally differentiated
organ. Conversely, peri-lesional mitosis of cardiomyocytes were discovered
initially by light microscopy and subsequently confirmed by more
sophisticated technologies. Controversial evidence of mechanisms underlying
myocardial regeneration has shown that adult cardiomyocytes are renewed
through a slow turnover, even in the absence of damage. This turnover is
ensured by the activation of rare clusters of progenitor cells interspersed
among the cardiac cells functionally mature. Cardiac progenitor cells
continuously interact with each other, with the cells circulating in the vessels
of the coronary microcirculation and myocardial cells in auto-/paracrine
manner. Much remains to be understood; however, the limited functional
recovery in human beings after myocardial injury clearly demonstrates weak
regenerative potential of cardiomyocytes and encourages the development of
new approaches to stimulate this process.
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S12-2
CELL THERAPy AFTER MyOCARDIAL INFARCTION: 
PRESENT AND FUTURE
Elisa-A. Liehn
Institute for molecular cardiovascular reserach, RWTH Aachen, Germany
eliehn@ukaachen.de 
Despite the extensive research, our current knowledge regarding the control
of molecular and cellular events after MI is still limited. Moreover, the most
promising stem cell-therapy has not offered satisfying results. Therefore, to
be able to create efficient therapies, we desperately need to understand how
all these processes are modulated and controlled.
The mature scar is a dynamic tissue, rich in cells, vascularized, metabolically
active and contractile. Therefore, we should be able to interfere in its
metabolism, and induce morphological and functional changes. Indeed, the
experimental intramyocardial injection of cells, one month after myocardial
infarction, induces cell-specific changes of the scar, improving ventricular
function. Despite the fact that cell therapy is considered a novel and potentially
new strategy in regenerative medicine, Recent studies imply that paracrine
effects and inflammatory modulations by transplanted cells are a key factor
for improvement of myocardial function. In this regard, we were able to show
that transplantation of biological inactive glass microspheres induced a
significant increase in ventricular contractility, but not the apoptotic bodies.
Therefore, we conclude that the underlaying mechanism of augmented heart
function after cell therapy might be based on inflammatory processes induced
by transplantation. 
This could represent a new approach in developing therapeutical strategies to
improve heart function in patients with extended scar-tissues, for whom all
current clinical treatment alternatives have been exhausted. 
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S12-3
CARDIOVASCULAR STEM CELLS: 
FROM REgENERATION TO ENgINEERINg
Maurizio Pesce
Laboratorio di Ingegneria Tissutale Cardiovascolare, Centro Cardiologico
Monzino, IRCCS, Milan, Italy 
maurizio.pesce@ccfm.it
The ability to produce differentiated cells maintaining tissue homeostasis is a
unique feature of stem cells. This makes them an ideal resource for cell
replacement strategies in tissues with ischemic disease. Transplanted cells,
regardless of whether they adhere to “stem” cell definition, are expected to
engraft into ischemic tissues, proliferate and differentiate into cells repairing
the damaged organs. While significant advancements have been made toward
the development of clinically approved stem cell preparation protocols, with
the introduction of “good manufacturing practice” (GMP) criteria, or the use
of “cell enhancement strategies”, to enhance innate stem cell functions, the
“bulk” expansion methods appear insufficient to maintain “stemness”
characteristics. In fact, culture in the presence of soluble cytokines or adhesion
onto plastic-made rigid surfaces with stiffness of several orders or magnitude
higher than tissue environment, does not preserve the innate ability of stem
cells to asymmetrically divide and self renew.
Merging stem cell biology with most recent advances in material screening,
bio-engineering and computer modeling is potentially of great help to
overcome this hurdle. In fact, the ability to assess cellular responses after
confinement into structures with defined bi- or three-dimensional (2D/3D)
shapes, specific chemical composition and controlled mechanical stimulation,
allows high throughput dissection of stem cells “functiotype” and, thus,
modeling a culture environment mimicking the complex biological
architecture.
In the course of the presentation, examples from our past and present
experience in cardiovascular stem cells science and emerging approaches of
high throughput biomaterial screening, bioengineering, bio-computing and
(epi)genetic profiling, will be presented as a next step in the devise of
enhanced cardiovascular tissue engineering and regenerative medicine.
100
S12-4
CARDIAC STEM CELLS: THE SOLUTION
Pieter A. Doevendans
Cardiology, Division Heart and Lungs, UMC Utrecht, 
The Netherlands
P.Doevendans@umcutrecht.nl 
The stem cell field is moving forward in the direction of the clinical arena.
By moving from bone marrow mononuclear cells to mesenchymal stem cells
has improved clinical outcome. The most recent trials on cardiac stem cells
are preliminary, but appear safe and the 1 year outcome is above all
expectations. The presentation will focus on the current knowledge we have
on cardiac stem cells from various sources and how they can be applied. Also
the necessity to differentiate these cells prior to injection will be discussed. In
the years ahead the battle between biology and technology will make the
developments even more interesting. Currently cardiac stem cells would
appear to provide the best solution.
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S12-5
CARDIAC STEM AND PROgENITOR CELLS By ELECTRON
MICROSCOPy/TOMOgRAPHy
Mihaela Gherghiceanu
“Victor Babeş” National Institute of Pathology, Bucharest, Romania
mihaela.gherghiceanu@ivb.ro
A highly heterogeneous population of cardiac stem (CSC) and progenitor
(CMP) cells has been described by in the mammalian adult heart, but the
ultrastructural identity of CSC in tissue remains unknown. Using electron
microscopy (EM), we found cells with stem features in the adult mouse heart.
These putative CSC are small, round cells, with large nucleus, few
endoplasmic reticulum cisternae and mitochondria, but numerous ribosomes.
CSC located in the epicardial stem cell niche (CSCN) undergo mitosis and
apoptosis. Beside CSC, CMP residing in the CSCN are easily identifiable by
EM. Cells with intermediate features between CSC and CMP could also been
seen. Moreover, EM shows that CMP are added to the adult cardiomyocytes
in the peripheral of working myocardium. Telocytes form a supportive
interstitial network for CSC and CMP in the stem cell niche. Complex
intercellular communication occurs between the telocytes and CMP through
electron-dense nanostructures or through shed vesicles. The presence of CSC
and CMP sustain a continuous cardiac renewal process in the adult mammalian
heart. 
This work was supported by a grant of the Romanian National Authority for
Scientific Research, CNCS – UEFISCDI, project number PN-II-ID-PCE-
2011-3-0134.
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S12-6
CyTOPROTECTION OF HEME OxygENASE-1 IN EMBRyONIC
STEM CELLS AND CARDIOVASCULAR SySTEM
Shaw-Fang Yet
National Health Research Institutes, Zhunan, Miaoli County, Taiwan
syet@nhri.org.tw 
Embryonic stem cells (ESCs) are promising donor sources in cell therapies
for various diseases. Although low levels of reactive oxygen species (ROS)
are necessary for the maintenance of stem cells, increased ROS levels initiate
differentiation and cell damage. Heme oxygenase (HO)-1 is a stress response
protein with antioxidative and anti-inflammatory properties. We hypothesized
that HO-1 plays critical roles in ESCs and cardiovascular system. To test our
hypothesis, we used induced pluripotent stem (iPS) cells that lack HO-1 and
HO-1 knockout mice in our in vitro and in vivo studies. In response to oxidant
stress, HO-1-deficient iPS cells accumulate higher levels of intracellular ROS
compared with wild-type ESCs and are more susceptible to oxidant-induced
cell death. Following LIF and feeder withdrawal, ESC marker gene levels are
significantly lower in HO-1-deficient iPS cells. Our results demonstrate that
a lack of HO-1 renders ESCs more prone to oxidative stress-induced cell death
and differentiation. In animals, lack of HO-1 worsens myocardial injury
whereas overexpression of HO-1 protects against myocardial infarction. In a
mouse model with angiotensin II infusion, HO-1-deficiency exacerbates
abdominal aortic aneurysm formation. Taken together, HO-1 confers
cytoprotection not only in ESCs but also in cardiovascular system.
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S-13 Symposium
“Blood Brain Barrier and angiogenesis –
role in neurodegeneration”
Chaired by: Carola Foerster, K. Jellinger
Date: Friday, June 8th
Starting time: 14:30 
Location: Hall B (Salonul Oglinzilor)
1. P. Religa
Cellular mechanisms of vascular structure formation
2. Carola Foerster
Role of the blood brain barrier in secondary brain injury
development - folly adaptations for survival?
3. D. Frenkel
Immunotherapy of cerebrovascular amyloidosis in a
transgenic mouse model
4. B.O. Popescu
Alteration of blood-brain barrier in neurodegenerative
diseases
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S13-1
CELLULAR MECHANISMS OF VASCULAR STRUCTURE
FORMATION
Piotr Religa 
Karolinska Institutet, Stockholm, Sweden
piotr.religa@ki.se 
The changes in the vascular structure occur in the most chronic diseases. In
cancer, most vessels do not fit into the conventional hierarchy of arterioles,
capillaries and venules. Abnormalities involve all components of the vessel
wall: endothelial cells, mural cells and basement membrane. Despite the
abnormalities, most tumor vessels do have endothelial cells and pericytes.
Alzheimer disease (AD) is associated with accumulation of amyloid-beta
peptide (Aβ) and microvascular changes in brain that impair blood flow.
Combination of these factors can lead to progression of AD. During
vasculogenesis, formation of first blood vessels is achieved by differentiation
of hemangiogenic stem cells from pluripotent mesenchymal cells, while during
angiogenesis new blood vessels form from already existing vessels. The newly
formed vessels are composed of endothelial cells and are not stable. Mural
cells such as pericytes and smooth muscle cells guide maturation of vessels
and their stabilisation. The vessels become also specialized. Unstable vessels
go into regression. Our research explores mechanisms involved in formation
of vascular structure in cancer and Alzheimer disease.Our performed study
indicates that VEGF affects small vessels and change vascular structure by
affecting endothelial cells and smooth muscle cells.
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S13-2
ROLE OF THE BLOOD BRAIN BARRIER 
IN SECONDARy BRAIN INJURy DEVELOPMENT - 
FOLLy ADAPTATIONS FOR SURVIVAL?
Ellaine Salvador1, Winfried Neuhaus1, Herman Koepsell2, 
Serge Thal3, Carola Förster1
1 Department of Anesthesia and Critical Care, University Wuerzburg,
Germany
2 Departement of Anatomy and Cell Biology I, University Wuerzburg,
Germany
3 Klinik für Anästhesiologie, University Mainz, Germany
Foerster_C@klinik.uni-wuerzburg.de 
Traumatic brain injury (TBI) is the leading cause of death in children and
young adults globally. Malignant cerebral edema plays a major role in the
pathophysiology which evolves after severe TBI. Added to this is the
significant morbidity and mortality from cerebral edema associated with acute
stroke, hypoxic ischemic coma, neurological cancers and brain infection.
Therapeutic strategies to prevent cerebral edema are limited and if brain
swelling persists beyond 24 h, the risks of permanent brain damage or
mortality are greatly exacerbated.
During traumatic brain injury (TBI) and stroke, both, oxygen and glucose
deprivation (OGD) may be encountered. Due to a higher demand for glucose
in the brain in these cases, enhanced levels of glucose transporters are
expressed, facilitated glucose transporter-1 (GLUT1) and sodium-dependent
glucose transporter-1 (SGLT1). Besides their function as energy supply,
glucose may influence brain water homeostasis by a direct hygroscopic effect;
a possible cause for early brain edema formation. The present study
investigated the expression of sodium-dependent glucose transporters (SGLT)
and the effect of their deficiency on brain edema formation after experimental
TBI.
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S13-3
IMMUNOTHERAPy OF CEREBROVASCULAR AMyLOIDOSIS IN
A TRANSgENIC MOUSE MODEL
V. Lifshitz, R. Weiss, D. Frenkel
Department of Neurobiology, George S. Wise Faculty of Life Sciences, 
The Department of Neurobiology, Tel Aviv University, Tel Aviv, Israel
dfrenkel@post.tau.ac.il
Cerebrovascular amyloidosis (CA) is due to amyloid accumulation in the
vessel walls leading to hemorrhagic stroke, and cognitive impairment. CA
increases dramatically with age, affecting more than 40% of people over the
age of 80 years, and is found in 80% of Alzheimer’s disease (AD) cases.
Transforming growth factor-β1 (TGF-β1) is a multifunctional cytokine has
profound effects on vasculogenesis, angiogenesis, and vessel wall integrity
expression levels. TGF-β1 levels correlate positively with the degree of
cerebrovascular amyloid in AD cases. We found that over-expression of TGF-
β1 in glia cells affects endothelial cells and peripheral immune cross talk,
leading to a reduction in macrophage activity, and to an age-related deposition
of amyloid around cerebral blood vessels. Weekly nasal vaccination of the
proteosome-based adjuvant, Protollin, which is well tolerated in humans,
potently decreases vascular amyloid in 13-month-old TGF-ß1 mice following
six weeks of treatment.  Using MRI we found that while PBS treated animals
showed a significant enlargement of the lateral ventricles area, Protollin
prevents further brain damage. Using an object recognition test, we found
significant improvement in cognition with the Protollin treated group. Our
results suggest a novel approach toward therapy for CA utilization of a
compound that has been safely tested in humans.
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S13-4
ALTERATION OF BLOOD-BRAIN BARRIER IN
NEURODEgENERATIVE DISEASES
Bogdan O. Popescu
Department of Neurology, University Hospital, School of Medicine, 
“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
“Victor Babeş” National Institute of Pathology, Bucharest, Romania
bogdan.popescu@jcmm.org
Neurodegenerative disorders represent frequent pathologies in the elderly,
affecting more than 7% of the population over 65’s and their prevalence further
increases with age. Current treatments for neurodegenerative conditions are
only symptomatic and all recent clinical trials designed to identify disease
modifying drugs failed. Even though new pathogenic mechanisms in
neurodegeneration might be still unraveled, the strategy of counteracting only
one such mechanism will probably continue to fail at a clinical level. Recently,
different research groups including our own identified blood-brain barrier
(BBB) alteration as an aggravating factor for neurodegeneration. Many
patients with Alzheimer’s disease (AD) or other neurodegenerative disorders
were documented to have BBB permeability alteration. No drug target at the
BBB level has been clinically tested yet. In this paper I review the data in the
field and I present our studies regarding altered expression of tight junction
proteins, such as occludin and claudins, in AD and vascular dementia brains. 
This paper is supported by the Sectorial Operational Programme Human
Resources Development (SOP HRD), financed from the European Social Fund
and by the Romanian Government under the contract number
POSDRU/89/1.5/S/64109.
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S-14 Symposium
“Response to oxidative stress”
Chaired by: Eugenia Manukhina, P. Singal
Date: Friday, June 8th
Starting time: 08:30 
Location: Hall B (Salonul Oglinzilor)
1. P. Singal
Subcellular adaptations in response to oxidative stress
2. A. Srivastava
Modulation of Oxidant-induced signaling by calcium and
calmodulin system in vascular smooth muscle cells
3. Eugenia Manukhina
Prevention of Nitric Oxide Overproduction in Protective
Effects of Adaptation to Hypoxia
4. Madhu B. Anand-Srivastava
Role of ROS in G Protein Expression and signaling in
Hypertension
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S14-1
SUBCELLULAR ADAPTATIONS IN RESPONSE TO 
OxIDATIVE STRESS
Pawan K. Singal
Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre
Winnipeg, Canada
PSingal@sbrc.ca 
It is known that overproduction of the proinflammatory cytokine, tumor
necrosis factor (TNFα), provokes tissue injury and organ failure. TNFα has
also been shown to be cardiodepressant and is considered to be responsible
for various cardiovascular complications.  Another cytokine, interleukin-10
(IL-10), has been shown to have anti-inflammatory properties.  We have shown
that IL-10 counterbalances many adverse cardiac effects of TNFα. TNFα-
induced oxidative stress as well as apoptosis were also shown to be mitigated
by IL-10.  Moreover, improvement in cardiac function after treatment with
various drugs was also shown to be associated with an increase in IL-10
content.  Based on these data, it is suggested that an optimal balance between
IL-10 and TNFα may be a new therapeutic strategy for maintaining cardiac
function in adverse conditions. Supported by the Canadian Institutes of Health
Research.
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S14-2
MODULATION OF OxIDANT-INDUCED SIgNALINg By
CALCIUM AND CALMODULIN SySTEM IN VASCULAR SMOOTH
MUSCLE CELLS
Ashok K. Srivastava
Research Centre, Centre hospitalier de l’Université de Montréal (CHUM),
Montreal, Canada
ashok.srivastava@umontreal.ca 
Increased oxidative stress has been implicated in the pathophysiology of
cardiovascular diseases. However, the precise mechanisms by which oxidants
contribute to the development of these diseases are not fully identified.
Previous work from our laboratory has demonstrated that exogenous hydrogen
peroxide (H2O2) activates several protein kinases, such as extracellular signal
regulated kinase1 and 2 (ERK1/2) and protein kinase B (PKB), key mediators
of growth promoting, proliferative and hypertrophic responses in vascular
smooth muscle cells (VSMC). Here, by using pharmacological and molecular
inhibitors we have investigated a potential role of Ca2+, calmodulin (CaM),
and CaM-dependent protein kinase II (CaMKII) in H2O2-induced
phosphorylation of ERK1/2 and PKB. BAPTA-AM, Calmidazolium and W-
7, KN-93 specific inhibitors/ antagonists of Ca2+, CaM and CaMKII,
attenuated H2O2 and glucose/glucose oxidase-induced ERK1/2 and PKB
phosphorylation in a dose-dependent fashion. Transfection of VSMC with
CaMKII auto-inhibitory peptide (AIP) corresponding to auto-inhibitory
domain (AA 281-309) of CaMKII or with siRNA of CaMKIIα, attenuated
H2O2-induced phosphorylation of ERK1/2 and PKB. In addition,
calmidazolium and KN-93 blocked H2O2-induced Pyk2 and IGF-1R
phosphorylation. H2O2 treatment also induced Thr286 phosphorylation of
CaMKII which was inhibited by both calmidazolium and KN-93. These results
demonstrate that Ca2+-dependent pathways play a critical role in triggering
oxidant-induced signaling events in VSMC. Supported by CIHR. 
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S14-3
PREVENTION OF NITRIC OxIDE OVERPRODUCTION IN
PROTECTIVE EFFECTS OF ADAPTATION TO HyPOxIA
Eugenia B. Manukhina1,2
Ludmila M. Belkina1, Olga L. Terekhina1, Denis V. Abramochkin2, 
Anna V. Goryacheva1, Robert T. Mallet3, H. Fred Downey3
1Institute of General Pathology and Pathophysiology, Moscow, Russia;
2M.V. Lomonosov Moscow State University;
3University of North Texas Health Science Center, Fort Worth, USA
Eugenia.Manukhina@unthsc.edu 
Nitric oxide (NO) overproduction is a detrimental factor involved in
pathogenesis of many diseases. In addition, to direct toxic effects of excessive
NO, it reacts with superoxide to produce peroxynitrite, an extremely strong
oxidant that damages lipids, DNA, carbohydrates and proteins. Adaptation to
hypoxia (AH) is known to be protective to the cardiovascular system. The
present study was focused on the role of preventing NO overproduction and
alleviating nitrosative stress in adaptation protection against ischemia and
reperfusion (IR) injury of the myocardium and blood vessels in rats. AH
considerably restricted IR arrhythmias, myocardial infarct size, and endothelial
dysfunction of coronary and non-coronary blood vessels. AH completely
prevented the IR-induced NO overproduction and accumulation of 3-
nitrotyrosine, a marker of nitrosative stress in the left ventricle. Also, AH
increased efficiency of NO storage in the vascular wall. Therefore, AH
cardioprotection is associated with prevention of NO toxicity in myocardium
during IR. Mechanisms for this cardioprotection may include reduced
expression and/or activity of NO synthases, and enhanced NO binding to NO
stores in vascular walls. In addition, the slight increase in NO production
associated with AH may prevent the subsequent NO overproduction by a
negative feedback mechanism. Supported by RFBR grant # 10-04-00980.
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S14-4
ROLE OF ROS IN g PROTEIN ExPRESSION AND SIgNALINg IN
HyPERTENSION
Madhu B. Anand-Srivastava
Department of Physiology, Faculty of Medicine, University of Montreal,
Montreal, Canada
ashok.srivastava@umontreal.ca 
Reactive oxygen species(ROS) that cause oxidative stress play a major role
in the pathophysioloy of cardiovascular diseases including hypertension. We
have previously shown an enhanced expression of Giα  proteins in VSMC
from SHR. The present study was undertaken to examine the role of ROS  and
ROS-mediated signaling in enhanced expression of Giα proteins in vascular
smooth muscle cells (VSMC) from SHR. The enhanced expression of Giα-2
and Giα-3 proteins in VSMC from SHR compared to WKY was attenuated
by antioxidants such as N-acetyl-L-cysteine (NAC) or diphenyleneiodonium
(DPI), captopril, losartan and AG1478, inhibitors of angiotensin converting
enzyme, AT1 receptor and epidermal growth factor receptor (EGFR)
respectively as well as by the siRNAs of AT1, cSrc and EGFR. Furthermore,
the enhanced phosphorylation of EGFR in VSMC from SHR  was  also
restored to control levels by captopril, losartan,  PP2, a c-Src inhibitor  and
N-acetyl-L-cysteine (NAC), whereas enhanced ERK1/2 phosphorylation was
attenuated by captopril, losartan, NAC and DPI. Furthermore, NAC also
restored the enhanced phosphorylation of c-Src in SHR to control levels. These
results suggest that the enhanced levels of endogenous Ang II in VSMC from
SHR, transactivate EGFR, which through MAP kinase signaling, enhances the
expression of Giα proteins and associated adenylyl cyclase signaling.
Supported by grant from CIHR.
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S-15 Symposium
“Telocytes”
- I -
Chaired by: G. Bussolati, X. Wang
Date: Friday, June 8th
Starting time: 17:00 
Location: Main Hall (Ronda)
1. x. Wang
Variation of lung telocytes among human, mouse and rat,
and their gene analysis comparing with mesenchymal
stem cells and fibroblasts
2. M.C. Rusu
Microanatomy of telocytes
3. Laura-C. Ceafalan
Telocytes and/or pericytes
4. g. Bussolati
Telocytes as origin of GISTs/PEComas
5. g. Radenkovic 
Patterns of occurrence of interstitial cells of Cajal in the
human digestive tract
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S15-1
VARIATION OF LUNg TELOCyTES AMONg HUMAN, MOUSE
AND RAT, AND THEIR gENE ANALySIS COMPARINg WITH
MESENCHyMAL STEM CELLS AND FIBROBLASTS
Yonghua Zheng1,2, Miaomiao Zhang 3,4, Mengjia Qian 3,4, Chunxue Bai1,2,
Xiangdong Wang1-4
1Department of Respiratory Medicine, 2Biomedical Research Center,
3Shanghai Respiratory Research Institute, 4Shanghai Key Laboratory of
Organ Transplantation, Zhongshan Hospital, Fudan University, Shanghai,
China
xiangdong.wang@clintransmed.org
Telocytes have been recently found as one of interstitial cells, with the
characteristic of small cellular body and extremely long telopodes, although
the functions and phenotypes remain unclear. The present studies aimed at
investigating morphological differences of telocytes among species and
locations, and specificities of gene profiles between telocytes, mesenchymal
stem cells and fibroblasts. We compared lung telocytes among human, mouse
and rat and different organs/tissues within rats or mice. We found similar
distributions of telocytes within the lung among human, mouse and rat, while
the cellular body of lung telocytes in human was longer and flatter with longer
telopodes and had more granular materials both in cellular body and telopodes
in human, as compared with mouse or rat. About 4000-5000 genes varied
between telocytes and others, of which more than 100, 50 or 30 folds of up-
regulated genes were 4, 9, or 17 vs stem cells and 10, 20, or 30 vs fibroblasts,
respectively. Thus, our data evidencd morphological variations of telocytes
between species and organs and different gene profiles of telocytes from
mesenchymal stem cells and fibroblast.
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S15-2
MICROANATOMy OF TELOCyTES
Mugurel C. Rusu
Anatomy Department, Dental School,
“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
anatomon@gmail.com
Telocytes (TCs) are stromal cells which, differently to canonical fibroblasts,
are not involved in collagen synthesis. TCs are defined by their moniliform
prolongations, the telopodes (Tps). Transmission electron microscopy (TEM)
is the only reliable tool to identify TCs/Tps. We evaluated in TEM various
tissues: (a) human tongue, larynx, greater omentum, heart, eye iris, trigeminal
and stellate ganglia, major salivary glands, oral mucosa, and skin; (b) rat
trachea, esophagus, thymus, and heart. Additional immunohistochemical tests
using antibodies for CD117/c-kit, CD34, PDGFR-α, vimentin, and alpha-
smooth muscle actin were performed. We got ultrastructural evidences of
TCs/Tp in the examined samples. Telocytes: (a) build stromal networks, shed
vesicles and exosomes; (b) build cellular tandems with other stromal cells; (c)
associate with endothelial cells and pericytes; (d) build concentric perineural
layers. Hybrid morphologies and/or lack of telopodes complicate the
diagnostic of TCs on grids. TEM results are better evaluated when the same
samples are labeled with specific antibodies, especially those for the cytokines
receptors CD117/c-kit and PDGFR. Stromal networking and signaling,
ensured by TCs, and their close relations with various other stromal cells
support a stromal signaling/firing system to be postulated. Funding:
POSDRU/89/1.5/S/64153.
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S15-3
TELOCyTES AND/OR PERICyTES
Laura-C. Ceafalan
“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
“Victor Babeş” National Institute of Pathology, Bucharest, Romania
lauraceafalan@yahoo.com 
A new line of evidence suggested that, in skeletal muscle, the perivascular
compartment represents a complex microenvironment,  with more elaborated
functions than pericytes, the archetypal phenotype of  pericapillary cells.  In
such areas, a niche for mesenchymal stem cells was recently described. Even
though most perivascular cells share a set of markers, they eventually acquire
a function related phenotype.  Disputed processes such as tissue remodeling
and repair rely on angiogenesis. Therefore, a hypothetical continuum,  from
mesenchymal cells to extracellular matrix secreting fibroblasts and to blood
vessel contractile phenotypes (pericytes or smooth muscle cells), must be taken
into consideration.
Recently, we demonstrated that this line of differentiation contains a new type
of interstitial cells, the telocytes. Based on their particular morphology, they
were detected in the perivascular compartment in many different organs. They
share some pericytes markers, like PDGFRβ, involved in vessel mural coat
recruitment and maintenance, but they also express growth factors like VEGF,
the trigger for angiogenesis.  Telocytes might represent a versatile population
capable of acquiring different fates depending on tissue distribution, including
microvessel recruitment and pericyte differentiation.
In view of such recent findings, the identity of the cells categorized so far as
pericytes by their immunophenotype should be reconsidered.
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S15-4
TELOCyTES AS ORIgIN OF gISTS/PECOMAS
Gianni Bussolati1,2, Carmen Ardeleanu1
1 “Victor Babeş” Institute, Bucharest, Romania 
2 Dept. Biomedical Science and Human Oncology - University of Torino,
Italy
gianni.bussolati@unito.it 
Immuno-phenotypic and structural data provide evidence for tracing tumors
of telocyte origin. We advanced the hypothesis that rare stromal tumors of
debated origin might derive from Telocytes. In fact, a fraction of both
PEComas (peri-endothelial cell tumors) and GISTs (gastro-intestinal and
extra-gastrointestinal stromal tumors) share expression of markers described
in Telocytes, .such as Melan A, MiTF. CD63, c-KIT (CD117), CD34, S-100,
SMA and VEGF. The hypothesis implies the existence, rather than of a
uniform entity, of a spectrum of lesions expressing different markers according
to the location and the differentiation status. Significantly, Telocytes show
distinctive ultrastructural features with thin, extended, projections loaded with
vesicles and micro-vescicles loading tumor cells have been described  in a
fraction of GISTs and of PEComas. In a series of 40 cases of GISTs we have
now searched for the expression of markers described also in Telocytes, but
proper of Melanomas while typical of PEComas and of CD63, a tetraspanin
protein originally described in melanomas and marking exosomes. The results
confirm the variability of expression and the existence of a spectrum of
differentiation.
Study conducted with the support of: Project PERSOTHER - SMIS-CSNR:
549/12.024
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S15-5
PATTERNS OF OCCURRENCE OF INTERSTITIAL CELLS OF
CAJAL IN THE HUMAN DIgESTIVE TRACT
Goran Radenkovic
Dept. Histology & Embryology, University of Nis Faculty of Medicine, 
Nis, Serbia 
radenkog@gmail.com
Although the exact role of Interstitial Cells of Cajal (ICC) is still controversial,
it is well known that these specialized network-forming cells are involved in
the control of digestive motility. It has been also confirmed that  ICC are
reduced or otherwise affected in several dysmotilities. That is the reason why
ICC have a central place in the research dealing with gastrointestinal
contractions.
ICC depend on stem cell factor (SCF) signaling via Kit for development and
maintenance. Recent studies have shown that ICC are not derived from the
neural crest, but rather are mesodermal in origin. However, some findings
suggest that the cells present in the inception myenteric plexus (MP) and
submucous plexus (SMP) ganglia are “responsible” for ICC differentiation,
representing probably the source of SCF.
At the end of the embryonic period of human development, c-kit
immunoreactive (c-kit IR) cells form an uninterrupted wide belt, extending
throughout the esophagus, stomach (except for the fundus), to the proximal
part of duodenum, around the inception of the MP ganglia. C-kit IR cells
appear in the distal duodenum and other parts of the gut originating from the
midgut, in the beginning of the fetal period of development, in the form of
narrow linear rows of cells, situated at the level of the MP. The pattern of
appearance of c-kit IR cells in the distal colon differs from that in the other
parts of the digestive tract. In terms of three dimensions, these cells are
arranged in two concentric tubes, one at the MP level, the other at the luminal
surface of the circular layer of the tunica muscularis, at the SMP level.
Simultaneous appearance of ICC at the SMP and MP levels in the terminal
portion of the colon can be explained by the fact that there are differences in
the migration of vagal neural crest cells in particular portions of the digestive
tube.
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S-16 Symposium
“Physical activity in adaptive medicine”
Chaired by: V. Adams, CH Kuo
Date: Sunday, June 10th
Starting time: 08:30 
Location: Hall A (Rapsodia)
1. V. Adams
Molecular alterations in the skeletal and diaphragmatic
muscle in heart failure: Impact of exercise training
2. Shyi-Wu Wang
Effect of passive repetitive isokinetic training on plasma
interleukin (IL-6 and IL-15)
3. M. Chia 
Focus on fitness and fatness in youth - foolhardy or
foolproof?
4. CH. Kuo
Physical activity and insulin resistance
5. I. Ehrenburg
Interval exercise training and interval hypoxic training
in  coronary heart disease patients
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S16-1
MOLECULAR ALTERATIONS IN THE SKELETAL AND
DIAPHRAgMATIC MUSCLE IN HEART FAILURE: IMPACT OF
ExERCISE TRAININg
Volker Adams
Heart Center Leipzig, Germany
adav@med.uni-leipzig.de 
During the last century, it became more and more evident, that in patients with
chronic heart failure the leading symptom exercise intolerance is mainly
determined by alterations in the skeletal and diaphragmatic muscle. In addition
several studies documented that exercise training is a powerful secondary
prevention tool to improve exercise intolerance. With respect to skeletal and
diaphragmatic muscle different molecular analysis techniques identified
several cellular systems to be affected in CHF and modulated by exercise
training programmes. During the presentation several of them will be
discussed including:
- Inflammatory system in the skeletal muscle
- Generation and detoxification of reactive oxygen species
- Anabolic and catabolic imbalance due to modulation of the ubiquitin
proteasome system
- Occurrence of apoptosis
- Modification of relevant proteins of the contractile machinery by
carbonylation and ubiquitinylation
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S16-2
EFFECT OF PASSIVE REPETITIVE ISOKINETIC TRAININg ON
PLASMA INTERLEUKIN (IL-6 AND IL-15)
Shyi-Wu Wang1*, Shu-Lin Lee2, Kenny Wen-Chyuan Chen3, 
Mei-Chich Hsu4, Mao-Kuan Su5
1Dept. of Physiol. & Pharmacol., Chang-Gung Univ., Taoyuan, 2Dept Nutrit.
& Health Sci., Chung Chou Ins. Tech, Changhua, 3Dept. Phys. Edu., Chang
Gung Tech. Univ., Taoyuan, 4Inst Sports Sci., Natl. Taiwan, Sport Univ,
Taoyuan, 5Phys. Edu. Room, Chang-Gung Univ., Taoyuan, Taiwan
swwang@mail.cgu.edu.tw 
The aim of the present study is to investigate the changes of plasma IL-6 and
IL-15 during and after passive repetitive isokinetic (PRI) training. For the first
experiment, thirty young male subjects were enrolled into the ten-week PRI
training program and were divided randomly into traditional, low- and high-
intensity PRI training groups. Another twenty-two male soccer athletes were
recruited into the second experiment, which acute heavy-resistance exercise
tests (AHRETs) were exerted before and after the ten-week PRI training. In
this study, these subjects were divided into low and high-intensity PRI training
groups. Blood sample were collected before and after training immediately.
Plasma cytokines’ concentrations were measured by ELISA. Significant
increased plasma IL-6 was found after high-intensity PRI training. Gradually
increased IL-15 level was observed during exercise and to a highest level at
post 0 D after low-intensity PRI-training, then decreased gradually during the
recovery period. In the second experiment, significant increase of IL-6 was
observed at post 120 h after low-intensity PRI training. Significant increase
of plasma IL-15 was found at post 0.5, 72, and 120 h, respectively, after PRI
training. Our results showed that significant increased plasma IL-15 was
observed after AHRET after low- and high-intensity PRI-training.
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S16-3
FOCUS ON FITNESS AND FATNESS IN ASIAN yOUTH-
FOOLHARDy OR FOOLPROOF?
Michael Chia 
National Institute of Education, Nanyang Technological University,
Singapore
michael.chia@nie.edu.sg
The keynote address will critically address the oft-held wisdoms of the
appropriate amounts of body fatness in child development through pre-
adolescence, adolescence and young adulthood and examine the reasons why
Singaporean youths lead entrenched sedentary lifestyles. Cogent evidence in
adulthood links a lack of physical activity and excessive body fatness with
certain disease states like metabolic syndrome and some cancer forms, yet the
issues of bodyweight satisfaction and disordered eating among Singaporean
youths also need to be addressed. The case for a holistic physical education
will be espoused.
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S16-4
ALTITUDE TRAININg AS A POWERFUL INTERVENTION IN THE
TREATMENT OF INSULIN RESISTANCE
Shu-Man Chen, Chia-Hua Kuo
Committee for General Education, Shih Hsin University, Taipei, Taiwan
Department of Sports Sciences, Taipei Physical Education College, Taipei,
Taiwan
kuochiahua@gmail.com 
Oxygen is the final acceptor of the electron transported from fat and
carbohydrate oxidation, which is the rate-limiting factor for cellular ATP
production. Prolonged moderate altitude hypoxia (ranged from 1700 to 2400
M), but not acute high attitude hypoxia (above 4000 M), can effectively
improve insulin sensitivity and glucose tolerance for humans and antagonizes
obese phenotype in the animals with the genetic defect. In humans, the
magnitude of the improvement is varying widely and correlated with baseline
plasma DHEA-S levels. Compared to training at sea-level, training at altitude
effectively decreases fat mass in parallel with increased muscle mass. This
change may be associated with increased perfusion of insulin and fuel towards
skeletal muscle that favors muscle competing postprandial fuel in circulation
against adipose tissues.
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S16-5
INTERVAL ExERCISE TRAININg AND INTERVAL HyPOxIC
TRAININg IN CORONARy ARTERy DISEASE PATIENTS
Igor Ehrenburg
Alexey Gorbatchenkov, Ludmila Kotlyarova
Russian State Medical University, Moscow, Russia
igorehrenburg@mail.ru 
The effects of interval exercise training (ET) on cycle ergometer (20-60
sessions, 5 or a week) and interval hypoxic training (HT) (15-30 sessions of
passive intermittent  hypoxia gas mixture breathing, 5 sessions a week) on
exercise tolerance and  arterial oxygen content in coronary artery disease
patients were investigated. The increase of exercise tolerance was more
pronounced in the ET group, and appeared only after 15 training sessions in
both groups. Plateau of training effect was observed after 60 sessions in ET
and after 25 sessions in HT. The training effect of HT was mainly due to the
improved of the external lung function and increase of  arterial oxygen content. 
We suggest that HT can be added to the exercise rehabilitation programs in
coronary artery disease patients and also may be a save tool to increase aerobic
capacity and exercise tolerance in the cases of objective and subjective
contraindications to ET. Other possibility is to start the rehabilitation with HT
and then switch it to the combination of ET and HT.
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S-17 Symposium
“Telocytes”
- II -
Chaired by: D. Cai, Maria Simonetta Faussone Pellegrini
Date: Saturday, June 9th
Starting time: 12:00 
Location: Hall B (Salonul Oglinzilor)
1. D. Cai
Cardiac telocytes in infarcted myocardium
2. Mihaela gherghiceanu 
Telocyte junctions: transcellular communication
3. S. Kostin
Telocytes and myocardial pathology
4. M. Taggart
A critical appraisal of the role(s) of smooth muscle
caveolae
5. T. gevaert
From interstitial cells to telocytes in the urinary tract:
probably more than passive bystanders
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S17-1
CARDIAC TELOCyTES IN INFARCTED MyOCARDIUM
Cai Dongqing
Key Laboratory for Regenerative Medicine, Ministry of Education, Ji Nan
University, Guangzhou, China
International Base of Collaboration for Science and Technology (JNU), The
Ministry of Science and Technology & Guangdong Province, China
Department of Developmental & Regenerative Biology, 
Ji Nan University
tdongbme@jnu.edu.cn 
Recently, a novel interstitial cell, named as telocyte, is found in myocardium.
In our previous study, we reported that the density of cardiac telocytes in base
part and the atrium-atria part was significantly higher than that in medium
part. In addition, the density of cardaic telocytes in subepicardium was
significantly higher than that in the endocardium. However, whether the
distribution of cardaic telocytes is experienced change under the MI is still
unclear. Our recent studies showed that the density of cardiac telocytes after
MI was decreased significantly comparing with non-LAD ligated control
group. In addition, it was found that the density of cardiac telocytes was
decreased consecutively. In addition, our preliminary results revealed that
intramyocardium injection of cardiac telocytes was able to improve the
function of infarcted heart after MI. Our findings suggested that cardiac
telocytes play an important role in integrity of myocardium and regeneration
of MI. 
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S17-2
TELOCyTE JUNCTIONS: TRANSCELLULAR COMMUNICATION
Mihaela Gherghiceanu
“Victor Babeş” National Institute of Pathology, Bucharest, Romania
mihaela.gherghiceanu@ivb.ro
Telocytes (TCs) form an interstitial network in adult heart. Using electron
microscopy (EM) and electron microscope tomography (ET), we investigated
the TC’s interstitial network and found that TCs establish ‘atypical’ junctions
with virtually all types of cells into the heart. EM and ET showed different
types of homocellular junctions connecting TCs in the network (puncta
adhaerentia minima, processus adhaerentes and manubria adhaerentia). TCs
and CMs are directly connected by ‘dot’ junctions with nanocontacts or
asymmetric junctions. Junctions between stem cells and TCs are either
‘stromal synapses’ or adhaerens junctions. TCs have direct cell-cell
nanocontacts with Schwann cells, endothelial cells and pericytes. All these
heterocellular contacts occur by means of minute junctions (point contacts,
nanocontacts and planar contacts; 10-30 nm). Therefore, the TC’s cardiac
network shape the structural support requisite to integrate the overall
‘information’ from vascular system (endothelial cells and pericytes), nervous
system (Schwann cells), immune system (macrophages, mast cells),
interstitium (fibroblasts, extracellular matrix), stem cells/progenitors and
working cardiomyocytes. This integrative interstitial system might sustain a
coordination of multicellular signals, essential for cardiac renewal,
regeneration and repair.
This work is supported by the Sectoral Operational Programme Human
Resources Development, financed from the European Social Fund and by the
Romanian Government under the contract number POSDRU/89/1.5/S/64109.
131
S17-3
TELOCyTES AND MyOCARDIAL PATHOLOgy
Sawa Kostin
Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany
Sawa.Kostin@mpi-bn.mpg.de 
Myocardial remodelling during heart failure involves the extracelluar matrix
(ECM). Telocytes (TC) are a novel type of myocardial interstitial cells. This
study aims at clarifying the role of TCs in ECM remodelling. Human samples
from patients with dilated, ischemic or inflammatory cardiomyopathy were
analyzed using electron and confocal microscopy. It has been revealed that
the number of TCs and telopodes decreased more than two- to three fold in
diseased human hearts as compared to controls. A significant correlation was
found to exist between the amount of fibrillar collagens and the decrease of
TCs in patients with cardiomyopathy. However, the amount of denaturated
collagens and an increase in the MMP/TIMP ratio was associated with
increased numbers of TCs. Taken together, this study demonstrates that TCs
and telopodes are very flexible cell/structures and respond promptly to any
quantitative and qualitative change in the ECM composition. Specifically, the
number of TCs in diverse cardiac diseases correlates negatively with the
degree of fibrosis and mature fibrillar collagens, and correlates positively with
denaturated collagens and the number of immunocompetent cells. Thius may
further impact the treatment of heart failure in the future.
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S17-4
A CRITICAL APPRAISAL OF THE ROLE(S) OF SMOOTH
MUSCLE CAVEOLAE
Michael J. Taggart
Institute of Cellular Medicine, Newcastle University, UK
michael.taggart@newcastle.ac.uk
It is 60 years since the pivotal electron microscopic findings of Palade
described omega-shaped invaginations of the plasmalemma now termed
caveolae.  Today we remain curious about the exact roles of these structures
in regulating spatiotemporal signalling.  The last decade has witnessed
considerable advances but there also remains controversies and inconsistencies
that need resolving.  In smooth muscle caveolae are often closely spaced,
within a few nanometres, to components of peripheral sarcoplasmic reticulum.
Ablation of caveola, e.g. by knockdown of one of their integral protein
components caveolin, results in changes in Ca2+ signalling at a local (Ca2+
sparks) and global (Ca2+ waves) level. Caveolins also regulate the (re)loca -
lisation of contractile or relaxatory signalling molecules. Both these findings
support the notion that the subcellular spaces created by the caveolae invaginations
offer a biophysically favourable environment for amplification of signal
transduction. Current important considerationsin the field are (i) In mechano -
sensitive cells such as smooth muscle, do caveolae act as mechanotransducers?
(ii) Are all the proposed molecular interactions with caveolin/caveolae possible
in one vascular cell type? (iii) What roles are there for other integral proteins
of caveolae? Finally, how similar are the roles of caveolae in smooth muscle
compared to other cell types?
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S17-5
FROM INTERSTITIAL CELLS TO TELOCyTES IN THE URINARy
TRACT: PROBABLy MORE THAN PASSIVE BySTANDERS
Thomas Gevaert
Université catholique de Louvain, Brussels, Belgium 
Thomas.Gevaert@med.kuleuven.be 
For many years interstitial cells have been studied in bladder. Two main
populations have been described: directly underneath the urothelium and in
between the detrusor smooth muscle bundles. Besides morphological
characterisation many functional data have been presented. Some populations
are thought to fulfil a sensing role whilst others might have pacemaking
properties.
It is remarkable that a heterogeneous terminology has been used for interstitial
cells in bladder: myofibroblasts, interstitial cells of Cajal or interstitial Cajal-
like cells. Reasons for this diverse nomenclature might be the use of different
experimental methods (electron microscopy versus light microscopy and
immunohistochemistry) and the use of different tissue hosts (human versus
animals).
Recently a novel stromal cell type was discovered and termed telocytes. These
cells are unique due to the presence of their telopodes.  Telocytes are organized
in networks and interconnected with gap junctions. Furthermore these cells
have a close relation with nerve endings, capillaries and inflammatory cells.
In human bladder telocytes have recently been characterized underneath the
urothelium. Furthermore changes in telocyte phenotype have been found in
bladder disease. In this presentation the localization and function of interstitial
cells in bladder is discussed with specific emphasis on the telocyte-population.  
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S-18 Symposium
“Measuring health”
Chaired by: F.A.C. Wiegant, Y. Kawai
Date: Saturday, June 9th
Starting time: 12:00 
Location: Main Hall (Ronda)
1. F.A.C. Wiegant
The challenge of measuring “health” using the ability to
adapt
2. Mei-Chich Hsu
Effects of swimming on metformin levels and insulin
sensitivity in insulin resistant rats
3. y. Kawai   
Effects of lower body positive pressure on cardiovascular
functions
4. Shin-Da Lee
Anti-apoptotic and pro-survival effects of exercise
training on hypertensive hearts
5. H. Morita
Cardiovascular adaptation/deconditioning in
gravitational change
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S18-1
THE CHALLENgE OF MEASURINg ‘HEALTH’ USINg THE
ABILITy TO ADAPT
Fred A.C. Wiegant
M.H. Bakker, W. Dijk, H.A.B. Prins, M.A.S. Huber
Institute of Education, Department of Biology, Faculty of Science, 
University College Utrecht, The Netherlands
F.A.C.Wiegant@uu.nl 
The pathophysiology of disease has dominated the scientific world ever since
Hippocrates. Lately, however, renewed interest has been observed in the
physiological background of the phenomenon of ‘health’.  Even though this
phenomenon has been defined in many different ways, an encompassing
definition that can be aptly used by the scientific community to measure and
quantify health has yet to be found. Processes known to underlie health are
homeostasis, allostasis, salutogenesis, resilience and robustness. Together, they
become especially important during times of stress and disbalance, making
the body adapt to a certain ‘threat’ and ensuring proper functioning of the body.
Focus on this ability to adapt could aid in defining health, and making health,
as such, measurable and quantifiable. Bodily adaptations can, for example, be
measured via a variety of changes in biomarkers and parameters, which link
to various organ systems. Potentially, specific stressors could be applied in
research, to which allostatic and homeostatic responses of tested individuals
might be measured. The addition of this dynamic (adaptive) component to our
current definitions of health would, thereby, mean a step forward in health
research and could stimulate the development of new therapeutic strategies,
optimizing current and future (preventive) health care.
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S18-2
EFFECTS OF SWIMMINg ON METFORMIN LEVELS AND
INSULIN SENSITIVITy IN INSULIN RESISTANT RATS
Mei-Chich Hsu1,
Kuei-Yu Chien1, Chia-Hua Kuo2, Chi-Chang Huan1, Ku-Fu Hsu1
1Graduate Institute of Sports Science, National Taiwan Sport University,
Taoyuan, Taiwan,  2Laboratory of Exercise Biochemistry,Taipei Physical
Education College, Taipei, Taiwan
meichich@gmail.com
Exercise or metformin medication is widely considered to increase insulin
sensitivity and protect against type 2 diabetes. We evaluated the swimming and
swimming training effects on the disposition and pharmacokinetics of metformin.
Both glucose and insulin levels were examined as well. For the single bout
swimming effect study, rats with fructose-induced insulin resistance were
assigned into four groups: control group (C, n=8), metformin group (M, n=8),
swimming group (S, n=8) and metformin with swimming group (MS, n=8). After
12 h of fasting, the S and MS group swam for 45 min, while the M and C groups
were placed in 4 cm deep water for the same time period. For the 4-wk swimming
training effect study, fructose-induced insulin resistant rats were assigned into
two groups (n=6/group): swimming training with metformin (SM), and non-
swimming training with metformin (CM). Blood samples were collected from
12 h-fasted rats at baseline and at different time points after an oral glucose
tolerance test (OGTT) with administration of a single dose of metformin. The
results from the single bout swimming effect study showed that the MS group
increased the time to the maximum concentration, the time to half-life
concentration and enhanced insulin sensitivity. This study suggested that
swimming before administration of metformin significantly improved insulin
sensitivity and the rate of metformin absorption. Results from the 4-wk swimming
training effect study revealed that both glucose and insulin levels in the SM group
were significantly lower than those in the CM group at 15 min following OGTT.
The maximum concentration and area under the serum concentration-time curve
for the SM group were significantly lower than CM group. Apparent volume of
the distribution and the time-averaged total body clearance for the SM group
were significantly faster than M group. There were no significant differences in
the time to maximum concentration or the time to half-life concentration between
two groups. Our data demonstrate that swimming training reduce the serum levels
of metformin. This study revealed that swimming training decreases the
metformin accumulation and has addictive effects on the glucose and insulin
response to metformin administration in insulin resistant rats.
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S18-3
EFFECTS OF LOWER BODy POSITIVE PRESSURE ON
CARDIOVASCULAR FUNCTIONS
Yasuaki Kawai, Satoshi Matsuo
Department of Adaptation Physiology, Faculty of Medicine, Tottori
University, Yonago, Japan
kawai@med.tottori-u.ac.jp 
Lower body positive pressure (LBPP) can be a useful tool for rehabilitation
for patients who suffer from pain, muscle weakness, and/or paralysis in the
lower extremities. Recently, we have developed a domestic LBPP apparatus
which consists of a treadmill in an airtight chamber and a blower outside the
chamber. Applying 20 mmHg of LBPP decreases the grand reaction force
(apparent body weight) of the subject by 31.0 ± 0.5 kgw. In the present study,
we investigated the effects of LBPP on cardiovascular responses during
standing still and walking. Exposure to 15 mmHg of LBPP decreased heart
rate during walking, but did not change blood pressure significantly in young
subjects. As the result, the double product (heart rate x systolic blood pressure)
was reduced significantly by the LBPP application. Applying LBPP also
decreased the leg circumference of the subjects, implying that it exerts an
edema-preventing effect. The present results suggest that LBPP can reduce
the work load of the heart and improve fluid turnover in the lower extremities.
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S18-4
ANTI-APOPTOTIC AND PRO-SURVIVAL EFFECTS OF ExERCISE
TRAININg
ON HyPERTENSIVE HEARTS
Shin-Da Lee, Chih-Yang Huang
1Department of Physical Therapy, Graduate Institute of Rehabilitation
Science, ChinaMedical University, Taichung, Taiwan 
2 Graduate Institute of Basic Medical Science, China Medical University,
Taichung, Taiwan
shinda@mail.cmu.edu.tw 
Activated cardiac apoptosis was found in hypertension but less information
regarding the effects of exercise training on cardiac apoptosis in hypertension
was available. The purpose of this study was to evaluate the anti-apoptotic
and pro-survival effects of exercise training on hypertensive hearts. Twenty-
eight spontaneously hypertensive rats were divided into sedentary group
(SHR) and underwent running exercise on treadmill 1 hour daily, 5 sections
per week, for 12 weeks (SHR-EX). Fourteen age-matched Wistar Kyoto rats
served as a sedentary normotensive group (WKY). After exercise training or
sedentary status, the excised hearts were measured by H&E staining, TUNEL
assay and Western Blotting. TUNEL-positive apoptotic cells became less in
SHR-EX groups than those in SHR. Protein levels of Fas ligand, Fas death
receptor, TNF-α, TNF receptor 1, Fas-associated death domain (FADD),
activated caspase-8, and activated caspase-3 (Fas-dependent apoptotic
pathways), as well as Bid, t-Bid, Bad, p-Bad, Bak, cytochrome c, activated
caspase 9 and activated caspase-3 (mitochondria-dependent apoptotic
pathways) were decreased in SHR-EX group compared with SHR group.
Protein levels of IGF1, IGF1R, p-PI3K, p-Akt, p-Bad, and Bcl2 (cardiac pro-
survival pathway) become more activated in SHR-EX groups than SHR and
WKY. Exercise training prevented hypertension-enhanced cardiac Fas-
dependent and mitochondria-dependent apoptotic pathways and enhanced
cardiac pro-survival pathway in rat models. Our findings demonstrate new
therapeutic effects of exercise training on hypertensive hearts for preventing
apoptosis and enhancing survival.
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S18-5
CARDIOVASCULAR ADAPTATION/DECONDITIONINg IN
gRAVITATIONAL CHANgE
Hironobu Morita
Department of Physiology, Gifu University Graduate School of Medicine, 
Gifu, Japan
zunzunmorita@gmail.com 
Gravity, not only a change in amount of gravity but also a change in direction
of gravity, is one of the most common and important disturbance for the
cardiovascular system. Hypergravity or posture change from recumbent to
upright increases hydrostatic pressure gradient and induces a footward fluid
shift, decreases venous return and cardiac output, and then decreases arterial
pressure. This decrease in arterial pressure is reflexively corrected by arterial
baroreflex and vestibulo-cardiovascular (V-C) reflex. However, the vestibular
system is known to be highly plastic, i.e., if subjects are exposed to different
gravitational environment, sensitivity of the vestibulo-cardiovascular reflex is
altered. Thus, it is possible that the sensitivity of vestibulo-cardiovascular
reflex is reduced after spaceflight or long term recumbency, and then
orthostatic hypotension is induced. To test this hypothesis, we examined: 1)
role of the V-C reflex in AP regulation during gravitational change in rats; 2)
whether plastic alteration of V-C reflex was induced by different gravitational
environment in rats; 3) methods for human subjects; 4) role of the V-C reflex
in AP regulation upon orthostasis in young and aged subjects.
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S-19 Symposium
“Epigenetics and adaptive medicine”
Chaired by: Ana-Maria Vlădăreanu, J. Drach
Date: Friday, June 8th
Starting time: 08:30 
Location: Hall C (Concerto)
1. R.A. Wang 
The molecular adaptation of cell
2. C. Müller-Tidow
Genetic mutations and epigenetic alterations in the
pathogenesis of myeloid malignancies
3. Ana-Maria Vlădăreanu
The adapted therapeutic strategies in hepatitis-viruses related
non-Hodgkin lymphomas - a concept of targeted approach
4. J. Drach
Mantle cell lymphoma: Recent advances in biology and
therapy with novel agents
5. R. Chaunchaiyakul 
Habitual physical activity and aging on respiratory function
6. B Mihălţan
Speleotherapy and respiratory diseases between myths
and realities
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S19-1
THE MOLECULAR ADAPTATION OF CELL
Rui-An Wang, Qing-Guo Yan
Department of Pathology and Pathophysiology, 
The Fourth Military Medical University, Xi’an, China
wangra@fmmu.edu.cn
Adaptation is an important concept in pathology. Although teleology is not
respected in the field of natural science, it is very useful and will be much
easier to get when we talk about the adaptation. The adaptation is the
adjustment of cells in response to the stress and changes of environment. It
serves two purposes, first to better fulfill the functional needs, and second,
more importantly, to survive. The adaptation includes hyperplasia, which is,
the increase in the number of cells; hypertrophy, the increase in the size of the
cells; metaplasia, the transformation of tissue types; and atrophy of cells,
which is the shrinkage of cell size. Today, we will mainly discuss the molecular
changes which facilitate the survival of the cells, and we will focused on
cancer cells. In contrary to the common notion that cancers are “resistant to
apoptosis”, the fact is, malignant tumors show more apoptosis and cancer cells
have short lifespan than their normal counterparts. The reasons account for
more apoptosis include poor blood supply, gene duplication errors, and
immune attacks from the host defense system. In cope with the increased
attrition of cells and to keep their families from distinction, cancer cells have
to make adjustments to adapt to the environment by increasing the expression
of proteins which promote cell survival, push forward the cell proliferation
cycle, and the proteins which help deal with the problem of hypoxia. That is
why we see increased levels of Bcl-2, cyclin D1, and HIF1 in many cancers,
what is known as the “oncogene addiction” of cancer. In fact, when the cells
adapt to the environment better, which is, die less as in the situation of
increased Bcl-2 expression, the tumor is less malignant and the patients tend
to have better prognosis. So the new concept of “molecular adaptation” is a
very useful concept for understanding biology of molecular events in the
cancer cells. 
S19-2
gENETIC MUTATIONS AND EPIgENETIC ALTERATIONS IN
THE PATHOgENESIS OF MyELOID MALIgNANCIES
Carsten Müller-Tidow
Department of Medicine A, University of Münster, Münster, Germany
muellerc@uni-muenster.de
Leukemias similar to other cancers are often composed of different cell types
and subclones with a clonal origin. Adaptive mechanisms are in place that lead
to selection of different clones in different phases of the disease. For example,
chemotherapy selects for drug resistant clones. Different leukemia
subpopulations are characterized by genetic and presumably epigenetic
features. Recent advances in sequencing technology allow genome wide
characterization of DNA mutation patterns and of epigenetic alterations. My
lab is interested in the mechanisms how epigenetic changes occur in Acute
Myeloid Leukemia and how these changes contribute to the leukemic
phenotype and drug resistance. In the presentation I will focus on genome
wide DNA methylation analyses in acute leukemia subtypes and the
association with specific oncogenes and patient age. In addition, I will
highlight the relevance of transgenic mouse models to alter DNA
methyltransferase (DNMT) activity during leukemogenesis. Our data show
that changes in DNMT activity can alter disease course and therapy
responsiveness in AML. Taken together, epigenetic alterations determine
disease course and drug response in AML.
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S19-3
THE ADAPTED THERAPEUTIC STRATEgIES IN HEPATITIS-
VIRUSES RELATED NON-HODgKIN LyMPHOMAS – A
CONCEPT OF TARgETED APPROACH
Ana-Maria Vlădăreanu1
Cristina Ciufu1, Ana-Maria Neagu1, Horia Bumbea1, Victoria Aramă2
1Hematology Department Universitary Emergency Hospital, Bucharest
2”Matei Balş” Institute of Infectious Diseases, Bucharest
anamariavladareanu@yahoo.com
Patients with chronic lymphoproliferative disorders (CLD) frequently
associate hepatitis viruses infections, and therefore pose problems both at
presentation and after chemotherapy is started. Specific antiviral therapy
protocols should be designed for these patients. There seems to be a strong
association between HCV and aggressive histological type of lymphomas. The
mechanisms involved in the clearance of HCV from plasma are unclear, but it
has been shown that the use of the anti-CD20 monoclonal antibody rituximab,
which reversibly depletes B cells, revealed a role on the control of plasma
hepatitis C viremia through humoral immunity. Hepatitis virus infection
through virus reactivation is a well-known complication, with high risk of
mortality in patients with hematological malignancies receiving chemotherapy.
Since HBV-infected patients develop severe liver dysfunction at a higher
incidence than either patients not infected with virus or HCV-infected patients
before starting chemotherapy, it is recommended that HBV-DNA should be
tested to detect HBV carriers. HBV reactivation occurred in some patients
who had been anti-HBs negative or had a low anti-HBs level. Also, when HBV
reactivation occurred, the rituximab chemotherapy could be continued after
entecavir administration reduced the HBV-DNA level. Entecavir prophylaxis
is not usually applied when immunochemotherapy was started, as it may be
started when HBV-DNA level increases. Lamivudine has been shown to have
prophylactic efficacy. Close monitoring during immunochemotherapy and at
least 6 months after is required, while maintaining a prophylactic antiviral
therapy to prevent this potentially fatal condition. The role and timing of
antiviral therapy remains to be defined – for HBV early therapy seems to
prevent viral reactivation, for HCV the best strategy has not been established.
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S19-4
MANTLE CELL LyMPHOMA: RECENT ADVANCES IN BIOLOgy
AND THERAPy WITH NOVEL AgENTS
Johannes Drach
Medical University of Vienna, Department of Medicine I, Clinical Division
of Oncology, Vienna, Austria
johannes.drach@meduniwien.ac.at
Mantle cell lymphoma (MCL) is a distinct entity within the non-Hodgkin’s
lymphomas, which is characterized by a specific genetic abnormality
(translocation t(11;14) leading to overexpression of cyclin-D1). Clinically,
patients with MCL have frequent extranodular manifestations including the
bone marrow and the gastrointestinal tract. Historically, MCL was associated
with a very poor prognosis (median survival 3 years), but recent developments
with more therapeutic options have changed the outcome of patients with
MCL. Treatment decisions are mainly based upon age and comorbidities. For
young patients with MCL (usually defined by the age below 65 years), an
intensive treatment approach including autologous stem cell transplantation
has been shown to be superior to standard-dose chemotherapy. Addition of
rituximab to induction chemotherapy improves response rates but its effect on
survival remains controversial. Therefore, the search for active drugs for the
treatment of MCL continues. Among chemotherapeutic agents, bendamustine
has shown promising activity, and preliminary data from a randomized clinical
trial suggest that rituximab/bendamustine may be equivalent to R-CHOP with
respect to treatment outcome, but with a more favorable toxicity profile.
Radioimmunotherapy appears to be of limited value in patients with bulky
lymphadenopathy. New agents with documented activity in MCL include
bortezomib, lenalidomide, and temsirolimus. Studies exploring combinations
of new agents with more traditional drugs are currently ongoing to better
define their role in the treatment algorithm of MCL.
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S19-5
HABITUAL PHySICAL ACTIVITy AND AgINg ON
RESPIRATORy FUNCTION
Rungchai Chaunchaiyakul
College of Sports Science and Technology, Mahidol University, Thailand
gmrungchai@gmail.com
Ageing causes opposite horizontal shifting of the lungs and chest wall
pressure-volume relationships, with unchanged compliances. The net results
of these curve shiftings imply that total elastic work remained unaltered.
Effects of habitual physical activity failed to decelerate age-related changes
in elastic works of breathing of total respiratory system, lungs and chest wall. 
Ageing causes different responses during exercise. Younger subjects showed
higher respiratory rate (fb), while the elderly subjects had higher tidal volume
(VT). In addition, all age groups increased VT during exercise primarily by
utilizing inspiratory reserve volume (IRV). Habitual physical activity results
in the higher VT with lower fb during exercise, in which greater minute
ventilation is produced. 
In conclusion, ageing causes the remarkable reductions of static and dynamic
lung volumes which resulted in simultaneous compliance shifting of lungs and
chest wall curves. Since total energy stored within the chest wall diminished
with advancing age, thus less energy to assist the consecutive inspiration.
Habitual physical activity fails to offset the age-related modification of
respiratory system.
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S19-6
SPELEOTHERAPy AND RESPIRATORy DISEASES BETWEEN
MyTHS AND REALITIES
Florin Mihălţan
National Institute of Pneumology „M.Nasta”, Bucharest, Romania
mihaltan@starnets.ro
History of speleotherapy is very charged. The special characteristics of the
micro-climate of a salt mine include stable air temperature, humidity and lack
of airborne pollutants such as pollens, and is unique to each mine. There are
many offers of such a therapy from halogenerators used to simulate the salted
atmosphere of salt mines to salt pipe , saltwater aerosol or salt mine micro-
climate. In our presentation we are discussing the benefits and the
consequences of such a therapy. This brought in the scientific articles
arguments pro and con and create a debate between the specialists. In the same
time we are trying to find the right place of speleotherapy in the algorithm of
chronic respiratory diseases without neglecting other benefits for other chronic
respiratory diseases. For Romania this type of therapy has a large offer coming
from the big number of salt mine underused now but arranged for assisting
this sample of patients.
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S-20 Symposium
“Modern trends in adaptive medicine”
Chaired by: C. Bai,  C. Ionescu-Târgovişte
Date: Sunday, June 10th
Starting time: 08:30 
Location: Hall B (Salonul Oglinzilor)
1. x. Wang 
Clinical bioinformatics in development of disease-
specific biomarkers
2. R.K. goyal
Changing Trends in the Treatment of Diabetic
Cardiomyopathy
3. C. Bai 
Cell phone based Telemedicine - brief introduction
4. R.K. Li
Myocardial Resident Bone Marrow Stem Cells Govern
Repair after Myocardial Infarction
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S20-1
CLINICAL BIOINFORMATICS IN DEVELOPMENT OF DISEASE-
SPECIFIC BIOMARKERS
Miaomiao Zhang, Bijun Zhu, Zhihui Ming, Lingyan Wang, Mengjia Qian,
Xiaocong Fang, Xiaojin Xu, Yonghua Zheng, Xiaoan Wu, Jiebai Zhou,
Yong Zhang, Ding Zhang, Beibei Wang, Lin Shi, Xiangdong Wang*
Biomedical Research Center, Department of Respiratory Medicine,
FudanUniversity Zhongshan Hospital, Shanghai, China. 
xiangdong.wang@clintransmed.org 
Clinical bioinformatics is a new emerging science combining clinical
informatics, bioinformatics, medical informatics, information technology,
mathematics, and omics science together. Clinical bioinformatics plays an
important role in a number of clinical applications. Clinical bioinformatics is
a new way to focus on the combination of clinical measurements and signs
with human tissue-generated bioinformatics, understand clinical symptoms
and signs, disease development and progress, and therapeutic strategy, and
map relationships that integrate discrete elements that collectively direct global
function within a particular -omic category, with clinical examinations,
pathology, biochemical analysis, imaging and therapies. A number of
methodologies and computational programs have been developed to integrate
selected proteins into the knowledge-based networks via the combination of
genomics, proteomics and bioinformatics. Alterations of network biomarkers
can be monitored and evaluated at different stages and time points during the
development of diseases, named dynamic network biomarkers. Dynamic
network biomarkers should be furthermore correlated with clinical informatics,
including patient complaints, history, therapies, clinical symptoms and signs,
physician’s examinations, biochemical analyses, imaging profiles, pathologies
and other measurements. Systems clinical medicine is coined as the integration
of systems biology, clinical phenotypes, high-throughout technologies,
bioinformatics and computational science to improve diagnosis, therapies and
prognosis of diseases. 
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S20-2
CHANgINg TRENDS IN THE TREATMENT OF DIABETIC
CARDIOMyOPATHy
Ramesh K. Goyal
SPP School of Pharmacy & Technological Management, 
NMIMS Deemed University, Mumbai, India
goyalrk@rediffmail.com 
In spite of identification of several humoral, cellular and sub-cellular targets
and developments of pharmacological and interventional methods for the
treatment of heart failure, there occurs greater cardiac morbidity and mortality
in diabetics. Even today one has to rely on the currently available antidiabetic,
antihypertensives, anti-atherosclerotic and antithrombotic drugs for diabetic
cardiomyopathy. In the early stages animal and clinical studies carried out on
proper selection of anti-diabetics and antihypertensives related to
cardioprotection, we justified the use of selective ACE inhibitors and calcium
channel blockers in NYHA class 1-3 cardiac failure. Similarly, metformin was
reported to be relatively cardio protective as compared to sulfonylureas, giving
rise to a new era for insulin sensitizers. Recently, there has been sudden growth
in the interest of herbal drugs for the treatment of various diseases. Many
herbal drugs as well as their semi-synthetic analogue have been reported for
the beneficial effect in heart failure. We report certain lead molecules like
gallotannin from Embelica officinalis, 6-gingerol from Zingiber officinalis,
and swertiamarin from Enicostemma littorale having beneficial effect in
diabetic associated cardioprotection. Since, no specific therapeutic strategies
has been recommended for diabetic cardiomyopathy, we propose have this as
holistic approach with potential herbal phytoconstituents having multiple
effects for the beneficial effect in diabetic cardiomyopathy.
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S20-3
CELL PHONE BASED TELEMEDICINE - BRIEF INTRODUCTION
Chunxue Bai
Shanghai Respiratory Research Institute (SRRI) 
Department of Pulmonary medicine, Zhongshan Hospital, 
Fudan University, Shanghai, China
bai.chunxue@zs-hospital.sh.cn
In 2008, cell phone user population hit 641 million while the mobile web user
population reached 117 million in China. The development of mobile
technology gives rise for greater potential to improve the public’s health.
Leveraging on the development of intelligent sensors, wireless transmitters,
as well as a dynamic medical network, we bring forth a new concept of cell
phone-based telemedicine specially catered for those suffering from chronic
respiratory diseases. Such a cost effective and convenient health care service
is enabled though the utilization of wifi/GPRS (General Packet Radio Service)
system and GPS (Global Positioning System) in widely used cell phones.
Briefly, our cell phone based medical service is composed with the following
components: (1) Terminal devices collecting information from the patient
whether audio, video, oxygen saturation, heart rate, lung function or other
physiological parameters. The breakthrough of our system is to integrate the
spirometer with a cell phone unit (ATS News, 2009, vol.35 no.7/8). (2)
Electronic transfer of such information over a distance through the internet
wirelessly; (3) Terminal devices by which doctors remotely receive patients’
information and send feedback and tailored advice back to the patients. (4) An
medical center for coordinating, providing technical services and regulating.
(5) Software enabling the interactive communication between doctors and
patients.
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S20-4
MyOCARDIAL RESIDENT BONE MARROW STEM CELLS
gOVERN REPAIR AFTER MyOCARDIAL INFARCTION
Ren-Ke Li
Toronto General Research Institute, University Health Network, Department
of Surgery, Division of Cardiovascular Surgery, University of Toronto,
Toronto, Ontario, Canada.
renkeli@uhnresearch.ca 
Heart failure results from cardiomyocyte necrosis after myocardial infarction.
The heart achieves limited repair through tissue resident and circulating stem-
cells. Resident cardiac stem-cells are believed to be a legacy of cardiac
development, residing in myocardial stasis but retaining a capacity for
regeneration in times of injury. Here we unveiled inceptive resident cardiac
stem-cells of hematopoietic origin that independently directs endogenous
repair.  Age negatively influences the cardiac recipient environment and the
functional capacity of stem-cell transplantation. Whereas a young environment
recuperates aged stem-cells, young stem-cells perform inadequately in aged
recipients. We address this paradox, revealing a third compartment: resident
cardiac stem-cells of hematopoietic origin that govern cardiac repair.
Rejuvenation of aged bone marrow increases the regenerative capacity by
restoring this resident cardiac stem-cell niche. Cardiac resident stem-cells play
an important role in restoration of cardiac function and repair. 
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S-21 Symposium
“Pathophysiology of adaptation”
Chaired by: M. Bhatia, Y.T. Konttinen
Date: Friday, June 8th
Starting time: 12:00 
Location: Hall B (Salonul Oglinzilor)
1. M. Bhatia
Hydrogen Sulfide and Substance P: Novel Inflammatory
Mediators and Therapeutic Targets for Acute
Pancreatitis
2. y.T. Konttinen
Osteoarthritis as an auto-inflammatory disease caused
by condrocyte-mediated inflammatory responses
3. Chen-Hsen Lee
The Management of Well Differentiated Thyroid Cancer
4. A. Cortot
IBD: from epidemiology to pathophysiology
5. J-F. Flejou
Premalignant Lesions in Inflammatory Bowel Diseases -
The Pathologist’s View
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S21-1
HyDROgEN SULFIDE AND SUBSTANCE P: NOVEL
INFLAMMATORy MEDIATORS AND THERAPEUTIC TARgETS
FOR ACUTE PANCREATITIS
Madhav Bhatia
Department of Pathology, University of Otago, Christchurch, New Zealand
madhav.bhatia@otago.ac.nz
Acute pancreatitis is a common clinical condition. Development of in vivo
experimental models of acute pancreatitis and associated systemic organ
damage has enabled us to study the role played by inflammatory mediators in
the pathogenesis of this condition. Hydrogen sulfide (H2S) plays an important
role in cardiovascular, central nervous and gastrointestinal systems and has
been shown to act as a vasodilator. We have also shown that H2S acts as a
mediator of inflammation. Substance P is an 11 amino acid neuropeptide that
is released from nerve endings in many tissues. Subsequent to its release,
substance P binds to neurokinin-1 (NK-1) receptors on the surface of effector
cells. Using experimental models, recent studies in our laboratory have
established the critical role played by H2S and substance P in acute
pancreatitis. Studies with experimental animal models of disease will help
define the role of these mediators in the pathogenesis of acute pancreatitis,
and can lead to the development of novel therapeutic approaches for this
condition.
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S21-2
OSTEOARTHRITIS AS AN AUTOINFLAMMATORy DISEASE
CAUSED By CHONDROCyTE-MEDIATED INFLAMMATION
Yrjö T. Konttinen
Institute of Clinical Medicine, Department of Medicine, Biomedicum,
Hus, Finland
yrjo.konttinen@helsinki.fi 
Osteoarthritis (OA) is considered primarily a disease of the hyaline articular
cartilage. First biomechanical stresses and strains, simple ”wear and tear”,
were considered as its root cause. Then it was realized that biochemical
inflammatory and degenerative processes play a role. We suggest a theoretical
framework, which ties the old and new dogma to each other, placing cartilage
matrix and chondrocyte at the centre stage and pointing the chondrocyte as
the primary inflammatory cell.
Articular cartilage lacks blood and lymphatic vessels. When subjected to “wear
and tear”, various cartilage extracellular matrix (ECM) derived
macromolecular patterns, now recognized as endogenous danger signals
(alarmins), are produced and released. Due to the lack of vasculature, they are
assumed to accumulate locally at high concentrations. Therefore, they
effectively stimulate chondrocytes and chondrocyte progenitors in situ via
various pattern-recognizing receptors (PRR), particularly Toll-like receptors
(TLRs). This leads to production of pro-inflammatory (e.g. tumour necrosis
factor-α) and analgetic (e.g. substance P) mediators. They can via the
interstitial cartilage and synovial fluid reach synovial membrane. This leads
to a secondary synovitis. Indeed, clinical symptoms in OA manifest as pain -
and pain cannot derive from the hyaline articular cartilage because it totally
lacks primary afferent nociceptive (PAN) nerves. It is assumed that after these
initial phases, secondary mechanisms, like local synovial synthesis and
imbalance of complement factors and inhibitors, takes over the perpetuation
and amplification of the secondary synovial inflammation.
New data on TLRs and chondrocyte activation in situ in osteochondral
cylinders, primary chondrocyte isolates and chondrogenic mesenchymal stem
cells will be presented, suggesting that the chondrocytes assume an
inflammatory, embryonal chondrocyte-like phenotype in OA.
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S21-3
THE MANAgEMENT OF WELL DIFFENRENTIATED 
THyROID CANCER
Chen-Hsen Lee
Taipei-Veterans General Hospital, National Yang-Ming University and 
Show-Chwan Health Care System, Chang-Hwa, Taipei, Taiwan
chlee@vghtpe.gov.tw
Thyroid cancer is the most common endocrine malignancy in clinical practice.
Most of the thyroid cancers are symptomless and may not progress in size.
Most clinicians are following the guidelines of American Thyroid Association
in the management on thyroid cancers. Surgeons rarely do not accept referrals
from endocrinologists. However, occasionally, there were difficulties in
fulfilling the requests of our medical counterparts as patients’ safety and
postoperative quality of life are our major concerns. 
It is generally agreed that a total or near total thyroidectomy is done for well
differentiated thyroid cancers (WDTC). A therapeutic central compartment
lymph node dissection is preferred in this Institution . Special cautions during
operation is needed in cncers with thyroiditis or after repeated fine needle
aspiration cytology tests as identification of anatomical structures may be
difficult due to dense adhesion. Re-do operation for recurrent thyroid cancers
carries higher risks of postoperative hoarseness and hypoparathyroidism. The
importance of pre-operative illustration and informed consent are emphasized.
WDTC’s with surrounding tissue invasion are managed individually.
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S21-4
INFLAMMATORy BOWEL DISEASES (IBD): FROM
EPIDEMIOLOgy TO PATHOPHySIOLOgy
Antoine Cortot
Centre Hospitalier Régional Universitaire de Lille, Lille , France
Antoine.CORTOT@chru-lille.fr 
IBD pathohysiology depends on the interaction between genetic susceptibility
and environmental factors leading to a deregulated immune intestinal response
resulting in bowel lesions. IBD epidemiologic variations with time (incidence,
prevalence) and space suggest a role for risk environmental factors, but so far
only smoking habits and appendectomy have been identified as influencing
the risk of occurrence and the course of IBD. Studies of monozygotic and
dizygotic twins and the existence of familial aggregation are strong evidence
for an important, but not exclusive, role for genetic susceptibility. Since the
discovery of NOD2 , the first Crohn’s disease –associated gene described in
2001, > 100 risk loci have been associated with IBD, some of them involved
in the regulation of innate and adaptive immunity , cellular clearance of
infectious agents (autophagy) and mucosal barrier function. Thus new
hypothesis include a key role of aberrant responses to the gut microbiome
which could be partly influenced by environmental factors generated by
modern life. The improvement of life hygiene, the change of food composition
and habits, the industrial pollution in developed countries, may influence,
directly or by the way of modifying intestinal human microbiota, IBD risk
occurrence.
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S21-5
PREMALIgNANT LESIONS IN INFLAMMATORy BOWEL
DISEASES - THE PATHOLOgIST’S VIEW
Jean-François Fléjou
Service d’Anatomie Pathologique, Pôle de Biologie Médicale et Pathologie
Equipe “Instabilité des Microsatellites et Cancers” , Hôpital Saint Antoine
Hôpitaux Universitaires Est Parisien, Paris, France 
jean-francois.flejou@sat.aphp.fr
Although most colorectal cancers (CRC) develop in patients with no previous
history of colorectal disease, some high-risk populations have been recognized.
This has been shown especially in patients with inflammatory bowel disease
(IBD). Recent studies have demonstrated that this increased risk is similar in
ulcerative colitis (UC) and Crohn’s disease (CD). It has also been shown that
in those patients with IBD, cancer develops through an inflammation –
dysplasia (or intra-epithelial neoplasia) – carcinoma sequence. Therefore,
surveillance is recommended in patients with IBD, resulting in the detection
of preneoplastic lesions, and also of cancers at an earlier stage with a better
prognosis. Dysplasia can present as a flat lesion, only detectable by systematic
random biopsies, or as raised lesions. There have recent changes in the
nomenclature and terminology of these lesions (ALM, DALM, RLD etc…)
that need clarification. The histological diagnosis of dysplasia remains a
difficult task, and it has to be made with recognized criteria and classification.
The recent WHO scheme recommends a two-tier classification (low-grade and
high grade), very close to the Riddell’s classification. It is also recommended
to confirm the diagnosis by a second (expert) observer, because of an imperfect
diagnostic reproducibility. Some new histological subtypes of dysplasia in IBD
have been recognized recently, including serrated and hypermucinous-villous
phenotypes. Among potential biomarkers of interest in complement to standard
histology, only p53 immunohistochemistry is really used in routine practice at
the present time. Interestingly, a basal pattern of p53 expression was described,
that may indicate a basal “cryptic” pattern of dysplasia in IBD, similar to the
crypt dysplasia described in Barrett’s oesophagus. However, the link still has
to be made between these morphological subtypes and the molecular alterations
involved in the carcinogenesis of colon mucosa in IBD. The example of
microsatellite instability is of interest in this field. 
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S-22 Symposium
“Current view on adaptive medicine”
Chaired by: A. Pries, M. Cinteză
Date: Saturday, June 9th
Starting time: 14:30 
Location: Hall B (Salonul Oglinzilor)
1. Patrizia d’Alessio
Quality of Life and inflammation: gender differences in
response to dietary supplementation in elderly people in
the RISTOMED study
2. Chi-Chang Huang
Potassium oxonate-induced proteinuria and acute renal
failure in vivo
3. A. Pries
Design principles of vascular networks:  Angiogenesis,
adaptation, heterogeneity and function
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S22-1
QUALITy OF LIFE AND INFLAMMATION: gENDER
DIFFERENCES IN RESPONSE TO DIETARy SUPPLEMENTATION
IN ELDERLy PEOPLE IN THE RISTOMED STUDy
Patrizia d’Alessio1
Rita Ostan2, Luzia Valentini3, Isabelle Bourdel-Marchasson4, Alessandro
Pinto5, Fabio Buccolini6, Claudio Franceschi2, Marie C. Bené7
1University Paris Sud-11 & Biopark Cancer Campus 1, Villejuif, France,
2Department of Experimental Pathology, University of Bologna, Italy, 3Charité –
Universitätsmedizin Berlin, Section of Nutritional Medicine of the Dept. Of
Gastroenterology, Berlin, Germany, 4CHU de Bordeaux, Univ. Bordeaux, Bordeaux,
France, 5Sapienza University of Rome, Experimental Medicine Department -
Medical Physiopathology, Food Science and Endocrinology Section - Food Science
and Human Nutrition Research Unit, Rome, Italy, 6Voxnet, Rome Italy, 7CHU Nancy
& University of Lorraine, France
patrizia.d-alessio@inserm.fr 
Twenty-five years of gender issue analysis have contributed to the re-definition
of diseases. Among cardio-vascular diseases, myocardial infarction is indeed
women killer number one, but its symptoms being different from those seen in
men, it has not been recognized as such for a long time. The effectiveness of
primary prevention of stroke and other cardiovascular events by aspirin tested
in seven trials, did not include women. Moreover, Dale et al. (2007) showed that
statins reduced the risk of stroke only in men. As cardiovascular disease, many
other health issues have been shown to be questionable when looked at under
the perspective of gender differences. Quality of Life parameters in particular
seem to be experienced differently by men and women. Depression, one of the
hallmarks of the aging population particularly affecting women because of
greater longevity, has a causal role in the development and course of
cardiovascular diseases. Epidemiological data demonstrate that depression or
anxiety are approximately twice as common in women as in men. This gender
difference emerges during adolescence and persists later in life and into old age.
It is moreover well recognized that inflammation contributes to the development
of depression. We report preliminary data on a study performed in elderly
healthy men and women, examining biological and behavioral responses after
56 days of a specifically developed dietary program with or without anti-
inflammatory dietary supplementation with an Orange Peel Extract (OPE)
containing d-Limonene, the European study RISTOMED. We show an impact
of both gender and initial inflammation status on the effects of dietary control.
OPE was more efficient in subjects with an initially high inflammatory status
and improved both IL-6 levels and depression scores in women.
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S22-2
POTASSIUM OxONATE-INDUCED PROTEINURIA AND ACUTE
RENAL FAILURE IN VIVO
Chi-Chang Huang1,, Wen-Ching Huang2, Mei-Chich Hsu1, Shao-Wen Hung3,
Chia-Chung Hou2,
1Graduate Institute of Sports Science, National Taiwan Sport University,
Taoyuan, Taiwan, 2Dong Jyu Biotechnology Corporation, Taipei,
Taiwan, ROC, 3Agricultural Biotechnology Research Center, Academia
Sinica, Taipei, Taiwan
(C.-C. Huang) john5523@mail.ntsu.edu.tw;  (C.-C. Hou) d8501002@tmu.edu.tw
Potassium oxonate (PO) is a pyrimidine phosphoribosyltransferasae (EC
2.4.2.10) competitive inhibitor, using as a modulator in a novel antineoplastic
combination agent, S-1. PO is also a selectively competitive uricase inhibitor,
which inhibits hepatic urate oxidase and induces hyperuricemia of
experimental animals. Herein, we report our finding that PO-insulted acute
renal failure (ARF), proteinuria and lethal toxicity in mice. The toxicity of
PO-induced ARF and the underlying molecular mechanisms is also
investigated. Male ICR mice were intraperitoneally administered with PO at
increasing doses of 0, 50, 100, 150, 200 and 250 mg/kg/day, designed as group
vehicle, PO-50, PO-100, PO-150, PO-200 and PO-250, respectively. The
results revealed that PO increased serum levels of potassium, uric acid,
markers of renal function (BUN and creatinine), inflammatory biomarker (NF-
kB p65 translocation) and ARF-related pathways (IL-6/IL-6sR/STAT3
phosphorylation). The urine production of PO-treated mice was significantly
decreased during 24 hours collection in a dose-dependent manner.
Additionally, with the decreased urine output, the mortality rate was increased
obviously. Only 25% (4/16) of animals survived after 48 h following PO-250
insult. We systematically investigated the possible signaling pathways leading
to PO-induced ARF which shed light on the potential renal toxicity of PO.
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S22-3
DESIgN PRINCIPLES OF VASCULAR NETWORKS: 
ANgIOgENESIS, ADAPTATION, HETEROgENEITy
AND FUNCTION
Axel R. Pries1,2
Bettina Reglin1, Timothy W. Secomb3
1Dept. of Physiology and CCR, Charité, Berlin, Germany
2Deutsches Herzzentrum Berlin, Berlin, Germany
3Dept. of Physiology, University of Arizona, Tucson, AZ, USA
axel.pries@charite.de
Microvascular networks are highly dynamical and heterogeneous structures
which have to provide low diffusion distances from capillaries to all tissue
cells as well as efficient convective distribution of blood flow through larger
vessels. The question how these different and partially conflicting tasks of
microvascular networks can be met by the biological processes for their
generation and adaptation (angioadaptation), including sprouting and splitting
angiogenesis, vascular pruning and structural diameter adaptation, is still under
debate.  A central concept is the combination of the stochastic processes of
angiogenesis with the refining processes of vascular diameter adaptation and
pruning. The adaptive processes exhibit negative feedback regulations of
relevant functional parameters, including wall shear stress and oxygen partial
pressure within a vessel and oxygenation of the tissue. This combination
allows the efficient generation and dynamic adaptation of vascular beds with
acceptable heterogeneity in levels of local supply. Compromised capability
for refining angioadaptation is probably involved in a number of pathologies
characterized by excessive heterogeneity, including tumour vascularization,
sepsis and aging. 
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general data
Romania is located at the crossroads of Central and Southeastern Europe.
Romania shares borders with: Hungary and Serbia to the west; Ukraine and
Moldova to the northeast and east, and Bulgaria to the south. The east side of
Romania is partially bordered by the Black Sea.
Romanian is the official language and is related to Italian, French, Spanish,
and Portuguese. 
Bucharest is the cultural, industrial, administrative and financial capital of
Romania, and is located in the southeast of the country. Bucharest lies on the
banks of the Dâmboviţa River.
Bucharest Climate
Bucharest has a continental climate, meaning hot and dry summers and
freezing cold winters. The temperature during the summer is pleasantly warm,
but sometimes there are heat waves. The air humidity is low. Occasionally
rainstorms could occur. 
In brief, weather in Bucharest in June is like a great summer day in England.
It can get quite hot in Bucharest, even in June.
Average temperature during June in Bucharest is 22°C during the day and a
low of 11°C at night. The evenings are warm, light clothes may be of use up
to around 10:00 PM.
Clothes recommended for June in Romania
Summer suits 
Summer clothes 
T-shirts
Waterproof clothes (rainy time intervals are possible). 
Romanian currency
The leu (Romanian pronunciation: singular - leu [lew], plural -  lei [lej]; code
RON) is the currency of Romania. It is subdivided into 100 bani (singular:
ban). 
Currency exchange in Romania
Foreign currencies could be exchanged at banks or authorized exchange
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offices (In Romanian: "casa de schimb" or "birou de schimb valutar").
International airports and larger hotels also offer currency exchange services.
Exchange rates (may slightly vary) for foreign currencies:
one US dollar = 3.5 Lei (3 lei and 50 bani) 
one British Pound = 5.5 Lei (5 lei and 54 bani)
one Euro = 4.5 Lei (4 lei and 50 bani)
Make sure that, before leaving Romania, you convert your leftover RON into
the currency of your choice.
Public Banks opening schedule in Romania is generally in between 09:00 –
17:00.
ATM (Bancomat)
You may find available ATM machines within main banks and shopping
centers. Few ATMs are available in remote areas or villages. ATMs that have
symbols for international networks such as STAR and PLUS will accept also
US/ Canadian banking cards.
Credit cards
Major credit cards including American Express, MasterCard and Visa are
accepted in large hotels, car rental companies and stores in the main cities. 
Contrary to practice in the United States, a PIN is usually required to make
credit card purchases. 
International dialing from Romania:
00 + country code + area code + telephone #
Romanian metric system 
Romania uses the metric system of weights and measures. Speed and distance
are measured in kilometers; goods in kilograms and liters; temperatures in
Celsius - Centigrade.
Electricity and Socket 
Romania's electrical current is 220V; 50Hz and sockets take the standard
continental European dual round-pronged plugs.
166
Places to see in Bucharest
Romanian Athenaeum symbol of national Romanian culture, built in 1888,
neoclassical style, with many elements of decoration of French typical
architecture;
Old Royal Court, the most significant historical remains of medieval era and
Old Court Church is the oldest example of religious architecture in Bucharest
existing from the feudal era.
Romanian Patriarchate built in 1656-1658 by the ruler Constantin Serban
Basarab.
Kretzulescu Church – the monument sums up, through its architecture, the art
in the Brâncoveanu era; it was built in 1720-1722 with great care from the
chancellor Iordache Safta Kretzulescu; the interior wall was painted by
Gheorghe Tattarescu between 1859 and 1860.
Stavropoleos Church, built in 1724-1730.
Ghica Palace, built in 1822 at the order of Prince Grigore Dimitrie Ghica, is
an imposing edifice, country representative for the Romanian neo-classical
style.
Ştirbei Palace, built in 1835 in neoclassical style according to the French
architect Sanjouand’s plans, today houses the Museum of Ceramics and Glass.
Şuţu Palace, Gothic style with Romanesque elements, dating from 1834, is
today the History and Art Museum for the city of Bucharest.
Cotroceni Palace, built in 1893 according to French architect Paul Gottereau’s
plans as the permanent residence of Crown Prince Ferdinand, is now in the
heritage of the presidential institution.
Parliament Palace, the greatest administrative construction in Europe, with
an area that ranks it second in the world (after the Pentagon) and with a volume
that places it on the third place in the world (after Cape Canaveral building -
U.S.A. and Quetzalcoatl pyramids - Mexico).
National History Museum of Romania, with over 50,000 pieces of great value,
illustrating the development of human society in our country.
National Art Museum of Romania, with over 70,000 pieces of Romanian and
universal art, hosting works by the Tatarescu, Aman, Grigorescu, Luchian,
Pallady, Tonitza, Brancusi, Paciurea, Rembrandt, Rubens, Delacroix, Renoir,
Monet etc.
Village Museum is one of the most interesting open-air ethnographical parks
in in the world.
“Grigore Antipa” Natural History Museum is the largest museum of its kind
in the Danubian countries, owning one of the richest collections of butterflies
in Europe.
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Art and History Museum of Bucharest has over 150,000 pieces that illustrate
the historical evolution of the city.
Arch of Triumph was completed in 1937 by the architect Petru Antonescu to
honor the victory of the Romanian Army in the First World War.
Smoking
Currently smoking is not allowed on public transportation and on most trains.
Luxury hotels have designated no-smoking floors and most restaurants have
no-smoking sections. Smoking is also prohibited in public places such as
hospitals, concert halls, and theatres.
general emergency phone number: 112
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